<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en">
    
    <head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
        <!-- AppResources meta begin -->
        <meta name="paf-app-resources" content="" />
                 <script type="text/javascript">var ncbi_startTime = new Date();</script>
            
        <!-- AppResources meta end -->
        
        <!-- TemplateResources meta begin -->
        <meta name="paf_template" content="" />

        <!-- TemplateResources meta end -->
        
        <!-- Logger begin -->
        <meta name="ncbi_db" content="books" /><meta name="ncbi_pdid" content="book-part" /><meta name="ncbi_acc" content="NBK1139" /><meta name="ncbi_domain" content="gene" /><meta name="ncbi_report" content="record" /><meta name="ncbi_type" content="fulltext" /><meta name="ncbi_objectid" content="" /><meta name="ncbi_pcid" content="/NBK1139/" /><meta name="ncbi_pagename" content="Hereditary Diffuse Gastric Cancer - GeneReviews® - NCBI Bookshelf" /><meta name="ncbi_bookparttype" content="chapter" /><meta name="ncbi_app" content="bookshelf" />
        <!-- Logger end -->
        
        <title>Hereditary Diffuse Gastric Cancer - GeneReviews® - NCBI Bookshelf</title>
        
        <!-- AppResources external_resources begin -->
        <link rel="stylesheet" href="/core/jig/1.14.8/css/jig.min.css" /><script type="text/javascript" src="/core/jig/1.14.8/js/jig.min.js"></script>

        <!-- AppResources external_resources end -->
        
        <!-- Page meta begin -->
        <meta name="robots" content="INDEX,FOLLOW,NOARCHIVE" /><meta name="citation_inbook_title" content="GeneReviews® [Internet]" /><meta name="citation_title" content="Hereditary Diffuse Gastric Cancer" /><meta name="citation_publisher" content="University of Washington, Seattle" /><meta name="citation_date" content="2018/03/22" /><meta name="citation_author" content="Pardeep Kaurah" /><meta name="citation_author" content="David G Huntsman" /><meta name="citation_pmid" content="20301318" /><meta name="citation_fulltext_html_url" content="https://www.ncbi.nlm.nih.gov/books/NBK1139/" /><meta name="citation_keywords" content="HDGC" /><meta name="citation_keywords" content="HDGC" /><meta name="citation_keywords" content="Cadherin-1" /><meta name="citation_keywords" content="CDH1" /><meta name="citation_keywords" content="Hereditary Diffuse Gastric Cancer" /><link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /><meta name="DC.Title" content="Hereditary Diffuse Gastric Cancer" /><meta name="DC.Type" content="Text" /><meta name="DC.Publisher" content="University of Washington, Seattle" /><meta name="DC.Contributor" content="Pardeep Kaurah" /><meta name="DC.Contributor" content="David G Huntsman" /><meta name="DC.Date" content="2018/03/22" /><meta name="DC.Identifier" content="https://www.ncbi.nlm.nih.gov/books/NBK1139/" /><meta name="description" content="Hereditary diffuse gastric cancer (HDGC) is an autosomal dominant susceptibility for diffuse gastric cancer, a poorly differentiated adenocarcinoma that infiltrates into the stomach wall causing thickening of the wall (linitis plastica) without forming a distinct mass. Diffuse gastric cancer is also referred to as signet ring carcinoma or isolated cell-type carcinoma. The average age of onset of HDGC is 38 years (range: 14-69 years). The majority of the cancers in individuals with a CDH1 pathogenic variant occur before age 40 years. The estimated cumulative risk of gastric cancer by age 80 years is 70% for men and 56% for women. Women are also at a 42% risk for lobular breast cancer." /><meta name="og:title" content="Hereditary Diffuse Gastric Cancer" /><meta name="og:type" content="book" /><meta name="og:description" content="Hereditary diffuse gastric cancer (HDGC) is an autosomal dominant susceptibility for diffuse gastric cancer, a poorly differentiated adenocarcinoma that infiltrates into the stomach wall causing thickening of the wall (linitis plastica) without forming a distinct mass. Diffuse gastric cancer is also referred to as signet ring carcinoma or isolated cell-type carcinoma. The average age of onset of HDGC is 38 years (range: 14-69 years). The majority of the cancers in individuals with a CDH1 pathogenic variant occur before age 40 years. The estimated cumulative risk of gastric cancer by age 80 years is 70% for men and 56% for women. Women are also at a 42% risk for lobular breast cancer." /><meta name="og:url" content="https://www.ncbi.nlm.nih.gov/books/NBK1139/" /><meta name="og:site_name" content="NCBI Bookshelf" /><meta name="og:image" content="https://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" /><meta name="twitter:card" content="summary" /><meta name="twitter:site" content="@ncbibooks" /><meta name="bk-non-canon-loc" content="/books/n/gene/hgc/" /><link rel="canonical" href="https://www.ncbi.nlm.nih.gov/books/NBK1139/" /><link rel="stylesheet" href="/corehtml/pmc/css/figpopup.css" type="text/css" media="screen" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books.min.css" type="text/css" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books_print.min.css" type="text/css" media="print" /><style type="text/css">p a.figpopup{display:inline !important} .bk_tt {font-family: monospace}  .first-line-outdent .bk_ref {display: inline}  .body-content h2, .body-content .h2  {border-bottom: 1px solid #97B0C8} .body-content h2.inline {border-bottom: none} a.page-toc-label , .jig-ncbismoothscroll a {text-decoration:none;border:0 !important} .temp-labeled-list  .graphic {display:inline-block !important} .temp-labeled-list  img{width:100%}</style><script type="text/javascript" src="/corehtml/pmc/js/jquery.hoverIntent.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/common.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/large-obj-scrollbars.min.js"> </script><script type="text/javascript">window.name="mainwindow";</script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/book-toc.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/books.min.js"> </script><meta name="book-collection" content="NONE" />

        <!-- Page meta end -->
    <link rel="shortcut icon" href="//www.ncbi.nlm.nih.gov/favicon.ico" /><meta name="ncbi_phid" content="CE8D35A4E03FF82100000000066001FE.m_12" />
<meta name='referrer' content='origin-when-cross-origin'/><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3852956/3985586/3808861/4121862/3974050/3917732/251717/4098876/14534/45193/4113719/3849091/3984811/3751656/4033350/3840896/3577051/3852958/4008682/3881636/3579733/4062871/12930/3964959/3854974/36029/4128070/9685/3549676/3609192/3609193/3609213/3395586.css" /><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3411343/3882866.css" media="print" /></head>
    <body class="book-part">
        <div class="grid">
            <div class="col twelve_col nomargin shadow">
                <!-- System messages like service outage or JS required; this is handled by the TemplateResources portlet -->
                <div class="sysmessages">
                    <noscript>
	<p class="nojs">
	<strong>Warning:</strong>
	The NCBI web site requires JavaScript to function. 
	<a href="/guide/browsers/#enablejs" title="Learn how to enable JavaScript" target="_blank">more...</a>
	</p>
	</noscript>
                </div>
                <!--/.sysmessage-->
                <div class="wrap">
                    <div class="page">
                        <div class="top">
                            <div class="universal_header" id="universal_header"><ul class="inline_list jig-ncbimenu ui-ncbimenu resources_list" id="navcontent"><li class="ui-ncbimenu-item-leaf ui-ncbimenu-item-first ui-helper-reset ui-ncbimenu-item-no-hlt"><a class="ui-ncbimenu-link-first" href="/" role="banner" title="NCBI Home" id="ncbihome" accesskey="1"><span class="offscreen_noflow">NCBI</span><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/img/28977" class="ncbi_logo" title="NCBI" alt="NCBI Logo" /></a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#maincontent" title="Skip to the content" tabindex="0" accesskey="3">Skip to main
                        content</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#navcontent" title="Skip to the navigation" tabindex="0" accesskey="4">Skip to
                        navigation</a></li><li id="resource-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first ui-helper-reset"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#resources">Resources</a></li><li id="all-howtos-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#howto">How To</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="/guide/browsers/#accesskeys" title="About My NCBI Accesskeys" tabindex="0" accesskey="0">About NCBI Accesskeys</a></li></ul><div class="myncbi"><span id="myncbiusername" style="display:none"><a href="/account/settings/" id="mnu" title="Edit account settings"></a></span><a accesskey="2" href="/myncbi/" id="myncbi" style="display:none">My NCBI</a><a href="/account/" id="sign_in">Sign in to NCBI</a><a href="/account/signout/" id="sign_out" style="display:none">Sign Out</a></div></div>
                            <div class="header">
    <div class="res_logo"><h1 class="res_name"><a href="/books/" title="Bookshelf home">Bookshelf</a></h1><h2 class="res_tagline"></h2></div>
    <div class="search"><form method="get" action="/books/"><div class="search_form"><label for="database" class="offscreen_noflow">Search database</label><select id="database"><optgroup label="Recent"><option value="books" selected="selected" class="last" data-ac_dict="bookshelf-search">Books</option></optgroup><optgroup label="All"><option value="gquery">All Databases</option><option value="assembly">Assembly</option><option value="biocollections">Biocollections</option><option value="bioproject">BioProject</option><option value="biosample">BioSample</option><option value="biosystems">BioSystems</option><option value="books" data-ac_dict="bookshelf-search">Books</option><option value="clinvar">ClinVar</option><option value="cdd">Conserved Domains</option><option value="gap">dbGaP</option><option value="dbvar">dbVar</option><option value="gene">Gene</option><option value="genome">Genome</option><option value="gds">GEO DataSets</option><option value="geoprofiles">GEO Profiles</option><option value="gtr">GTR</option><option value="homologene">HomoloGene</option><option value="ipg">Identical Protein Groups</option><option value="medgen">MedGen</option><option value="mesh">MeSH</option><option value="ncbisearch">NCBI Web Site</option><option value="nlmcatalog">NLM Catalog</option><option value="nuccore">Nucleotide</option><option value="omim">OMIM</option><option value="pmc">PMC</option><option value="popset">PopSet</option><option value="probe">Probe</option><option value="protein">Protein</option><option value="proteinclusters">Protein Clusters</option><option value="pcassay">PubChem BioAssay</option><option value="pccompound">PubChem Compound</option><option value="pcsubstance">PubChem Substance</option><option value="pubmed">PubMed</option><option value="snp">SNP</option><option value="sparcle">Sparcle</option><option value="sra">SRA</option><option value="structure">Structure</option><option value="taxonomy">Taxonomy</option><option value="toolkit">ToolKit</option><option value="toolkitall">ToolKitAll</option><option value="toolkitbookgh">ToolKitBookgh</option></optgroup></select><div class="nowrap"><label for="term" class="offscreen_noflow" accesskey="/">Search term</label><div class="nowrap"><input type="text" name="term" id="term" title="Search Books. Use up and down arrows to choose an item from the autocomplete." value="" class="jig-ncbiclearbutton jig-ncbiautocomplete" data-jigconfig="dictionary:'bookshelf-search',disableUrl:'NcbiSearchBarAutoComplCtrl'" autocomplete="off" data-sbconfig="ds:'no',pjs:'no',afs:'no'" /></div><button id="search" type="submit" class="button_search nowrap" cmd="go">Search</button></div></div></form><ul class="searchlinks inline_list"><li>
                        <a href="/books/browse/">Browse Titles</a>
                    </li><li>
                        <a href="/books/advanced/">Advanced</a>
                    </li><li class="help">
                        <a href="/books/NBK3833/">Help</a>
                    </li></ul></div>
</div>

                            
                            
                        <!--<component id="Page" label="headcontent"/>-->
                            
                        </div>
                        <div class="content">
                            <!-- site messages -->
                            <!-- Custom content 1 -->
<div class="col1">
    
</div>

<div class="container">
    <div id="maincontent" class="content eight_col col">
        <!-- Custom content in the left column above book nav -->
        <div class="col2">
            
        </div>
        
        <!-- Book content -->
        

        <!-- Custom content between navigation and content -->
        <div class="col3">
            
        </div>
        
        <div class="document">
            <div class="pre-content"><div><div class="bk_prnt"><p class="small">NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.</p><p>Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. </p></div><div class="iconblock clearfix whole_rhythm no_top_margin bk_noprnt"><a class="img_link icnblk_img" title="All GeneReviews" href="/books/n/gene/"><img class="source-thumb" src="/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" alt="Cover of GeneReviews®" height="100px" width="80px" /></a><div class="icnblk_cntnt eight_col"><h2>GeneReviews<sup>®</sup> [Internet].</h2><a data-jig="ncbitoggler" href="#__NBK1139_dtls__">Show details</a><div style="display:none" class="ui-widget" id="__NBK1139_dtls__"><div>Adam MP, Ardinger HH, Pagon RA, et al., editors.</div><div>Seattle (WA): <a href="http://www.washington.edu" ref="pagearea=page-banner&amp;targetsite=external&amp;targetcat=link&amp;targettype=publisher">University of Washington, Seattle</a>; 1993-2019.</div></div><div class="half_rhythm"><ul class="inline_list"><li style="margin-right:1em"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a></li></ul></div><div class="bk_noprnt"><form method="get" action="/books/n/gene/" id="bk_srch"><div class="bk_search"><label for="bk_term" class="offscreen_noflow">Search term</label><input type="text" title="Search GeneReviews" id="bk_term" name="term" value="" data-jig="ncbiclearbutton" /> <input type="submit" class="jig-ncbibutton" value="Search GeneReviews" submit="false" style="padding: 0.1em 0.4em;" /></div></form><div><ul class="inline_list"><li><a href="/books/n/gene/advanced/">GeneReviews Advanced Search</a></li><li style="margin-left:.5em"><a href="/books/n/gene/helpadvsearch/">Help</a></li></ul></div></div></div><div class="icnblk_cntnt two_col"><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/hcp/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/hered-drta/" title="Next page in this title">Next &gt;</a></div></div></div></div></div>
            <div class="main-content lit-style" itemscope="itemscope" itemtype="http://schema.org/CreativeWork"><div class="meta-content fm-sec"><h1 id="_NBK1139_"><span class="title" itemprop="name">Hereditary Diffuse Gastric Cancer</span></h1><div itemprop="alternativeHeadline" class="subtitle whole_rhythm">Synonym: HDGC</div><p class="contrib-group"><span itemprop="author">Pardeep Kaurah</span>, MSc, PhD and <span itemprop="author">David G Huntsman</span>, MD.</p><a data-jig="ncbitoggler" href="#__NBK1139_ai__" style="border:0;text-decoration:none">Author Information</a><div style="display:none" class="ui-widget" id="__NBK1139_ai__"><div class="contrib half_rhythm"><span itemprop="author">Pardeep Kaurah</span>, MSc, PhD<div class="affiliation small">Department of Medical Genetics<br />University of British Columbia<br />Vancouver, British Columbia, Canada<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ac.cb.recnaccb@haruakp" class="oemail">ac.cb.recnaccb@haruakp</a></div></div></div><div class="contrib half_rhythm"><span itemprop="author">David G Huntsman</span>, MD<div class="affiliation small">Faculty of Medicine<br />University of British Columbia<br />Vancouver, British Columbia, Canada<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ac.cb.recnaccb@amstnuhd" class="oemail">ac.cb.recnaccb@amstnuhd</a></div></div></div></div><p class="small">Initial Posting: <span itemprop="datePublished">November 4, 2002</span>; Last Update: <span itemprop="dateModified">March 22, 2018</span>.</p><p><em>Estimated reading time: 31 minutes</em></p></div><div class="jig-ncbiinpagenav body-content whole_rhythm" data-jigconfig="allHeadingLevels: ['h2'],smoothScroll: false" itemprop="text"><div id="hgc.Summary" itemprop="description"><h2 id="_hgc_Summary_">Summary</h2><div><h4 class="inline">Clinical characteristics.</h4><p>Hereditary diffuse gastric cancer (HDGC) is an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> susceptibility for diffuse gastric cancer, a poorly differentiated adenocarcinoma that infiltrates into the stomach wall causing thickening of the wall (<i>linitis plastica</i>) without forming a distinct mass. Diffuse gastric cancer is also referred to as signet ring carcinoma or <a class="def" href="/books/n/gene/glossary/def-item/isolated/">isolated</a> cell-type carcinoma. The average age of onset of HDGC is 38 years (range: 14-69 years). The majority of the cancers in individuals with a <i>CDH1</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> occur before age 40 years. The estimated cumulative risk of gastric cancer by age 80 years is 70% for men and 56% for women. Women are also at a 42% risk for lobular breast cancer.</p></div><div><h4 class="inline">Diagnosis/testing.</h4><p>A diagnosis of HDGC is established in a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> with:</p><ul><li class="half_rhythm"><div>Diffuse gastric cancer (DGC) and a family history of one or more first- or second-degree relatives with GC; OR</div></li><li class="half_rhythm"><div>A personal and/or family history of DGC diagnosed before age 40 years; OR</div></li><li class="half_rhythm"><div>A personal and/or family history of DGC and LBC, one diagnosed before age 50 years.</div></li></ul><p>If clinical features and family history are inconclusive, identification of a <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> <a class="def" href="/books/n/gene/glossary/def-item/germline/">germline</a> <i>CDH1</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> by <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> confirms the diagnosis and allows for family studies.</p></div><div><h4 class="inline">Management.</h4><p><i>Treatment of manifestations:</i> Ideally, management of individuals who have a <i>CDH1</i> cancer-predisposing variant is either intense surveillance for early detection and treatment of gastric cancer or prophylactic total gastrectomy. Care by a multidisciplinary team comprising those with expertise in medical genetics, gastric surgery, gastroenterology, pathology, and nutrition is recommended. For women, referral to a high-risk breast cancer clinic is recommended; prophylactic mastectomy may be considered.</p><p><i>Surveillance</i>: To date, the optimal management of individuals at risk for a cancer-predisposing variant has been controversial because of the unproven value of surveillance regimes and the potential morbidity and mortality from prophylactic gastrectomy.</p><p><i>Pregnancy management</i>: Women who have undergone prophylactic total gastrectomy (PTG) and are pregnant should be followed closely by their physician and a dietician who is aware of the situation.</p></div><div><h4 class="inline">Genetic counseling.</h4><p>Hereditary diffuse gastric cancer is inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> manner. The vast majority of individuals with a <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> predisposing to diffuse gastric cancer have inherited it from one parent. <i>De novo</i> pathogenic variants have been reported. Each child of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> has a 50% risk of inheriting the cancer-predisposing variant. Prenatal testing for pregnancies at increased risk is possible if the pathogenic variant in the family is known; however, requests for prenatal testing for conditions that (like HDGC) do not affect intellect and have some treatment available are not common.</p></div></div><div id="hgc.Diagnosis"><h2 id="_hgc_Diagnosis_">Diagnosis</h2><div id="hgc.Suggestive_Findings"><h3>Suggestive Findings</h3><p>According to the latest International Gastric Cancer Linkage Consortium (IGCLC) consensus guidelines [<a class="bk_pop" href="#hgc.REF.van_der_post.2015.361">van der Post et al 2015</a>] (see <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4453626/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">full text</a>), hereditary diffuse gastric cancer (HDGC) <b>should be suspected</b> in a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> with ANY of the following:</p><ul><li class="half_rhythm"><div>A diagnosis of gastric cancer and a family history of one or more individuals with gastric cancer, in which one <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual has confirmed diffuse gastric cancer (DGC)</div></li><li class="half_rhythm"><div>A diagnosis of DGC occurring before age 40 years, regardless of family history</div></li><li class="half_rhythm"><div>A personal and/or family history of DGC and lobular breast cancer (LBC), with at least one individual diagnosed with one of these cancers before age 50 years</div></li></ul><p>In addition, <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> should be considered in a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> with any of the following:</p><ul><li class="half_rhythm"><div>A diagnosis of DGC and pathologically confirmed in situ signet ring cells and/or pagetoid spread of signet ring cells adjacent to DGC</div></li><li class="half_rhythm"><div>A diagnosis of DGC and a family history of two first- or second-degree relatives with DGC or LBC</div></li><li class="half_rhythm"><div>A diagnosis of DGC and a personal or family history of cleft lip/palate</div></li></ul></div><div id="hgc.Establishing_the_Diagnosis"><h3>Establishing the Diagnosis</h3><p>A clinical diagnosis of HDGC <b>is established</b> in a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> with diffuse gastric cancer confirmed on endoscopic biopsy AND one of the following:</p><ul><li class="half_rhythm"><div>A family history of one or more first- or second-degree relatives with gastric cancer</div></li><li class="half_rhythm"><div>A personal and/or family history of one individual with DGC diagnosed before age 40 years</div></li><li class="half_rhythm"><div>A personal and/or family history of DGC and LBC, one diagnosed before age 50 years</div></li></ul><p>If clinical features and family history are inconclusive, identification of a <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in <i>CDH1</i> by <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> (see <a class="figpopup" href="/books/NBK1139/table/hgc.T.molecular_genetic_testing_used_in/?report=objectonly" target="object" rid-figpopup="fighgcTmoleculargenetictestingusedin" rid-ob="figobhgcTmoleculargenetictestingusedin">Table 1</a>) confirms the diagnosis and allows for family studies. Therefore, molecular testing is recommended in all individuals with one of the <a href="#hgc.Suggestive_Findings">Suggestive Findings</a> and in individuals with a clinical diagnosis of HDGC.</p><p>Molecular genetic testing approaches can include <b>single-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> testing</b> and use of a <b><a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a></b>:</p><ul><li class="half_rhythm"><div class="half_rhythm"><b>Single-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> testing.</b> Sequence analysis of <i>CDH1</i> is performed first and followed by gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a> if no <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> is found.</div></li><li class="half_rhythm"><div class="half_rhythm"><b>A <a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a></b> that includes <i>CDH1</i> and other genes of interest (see <a href="#hgc.Differential_Diagnosis">Differential Diagnosis</a>) may also be considered. Note: (1) The genes included in the panel and the diagnostic <a class="def" href="/books/n/gene/glossary/def-item/sensitivity/">sensitivity</a> of the testing used for each <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> vary by laboratory and are likely to change over time. (2) Some multigene panels may include genes not associated with the condition discussed in this <i>GeneReview</i>; thus, clinicians need to determine which multigene panel is most likely to identify the genetic cause of the condition at the most reasonable cost while limiting identification of variants of <a class="def" href="/books/n/gene/glossary/def-item/uncertain-significance/">uncertain significance</a> and pathogenic variants in genes that do not explain the underlying <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a>. (3) In some laboratories, panel options may include a custom laboratory-designed panel and/or custom phenotype-focused <a class="def" href="/books/n/gene/glossary/def-item/exome/">exome</a> analysis that includes genes specified by the clinician. (4) Methods used in a panel may include <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a>, <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a>, and/or other non-sequencing-based tests.</div><div class="half_rhythm">For an introduction to multigene panels click <a href="/books/n/gene/app5/#app5.Multigene_Panels">here</a>. More detailed information for clinicians ordering genetic tests can be found <a href="/books/n/gene/app5/#app5.Multigene_Panels_FAQs">here</a>.</div></li></ul><div id="hgc.T.molecular_genetic_testing_used_in" class="table"><h3><span class="label">Table 1. </span></h3><div class="caption"><p>Molecular Genetic Testing Used in Hereditary Diffuse Gastric Cancer</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1139/table/hgc.T.molecular_genetic_testing_used_in/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__hgc.T.molecular_genetic_testing_used_in_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_hgc.T.molecular_genetic_testing_used_in_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Gene&#x000a0;<sup>1</sup></th><th id="hd_h_hgc.T.molecular_genetic_testing_used_in_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Test Method</th><th id="hd_h_hgc.T.molecular_genetic_testing_used_in_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Proportion of Probands with a Pathogenic Variant&#x000a0;<sup>2</sup> Detectable by This Method</th></tr></thead><tbody><tr><td headers="hd_h_hgc.T.molecular_genetic_testing_used_in_1_1_1_1" rowspan="2" scope="row" colspan="1" style="text-align:left;vertical-align:middle;"><i>CDH1</i></td><td headers="hd_h_hgc.T.molecular_genetic_testing_used_in_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Sequence analysis&#x000a0;<sup>3</sup></td><td headers="hd_h_hgc.T.molecular_genetic_testing_used_in_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">30%-50%&#x000a0;<sup>4</sup></td></tr><tr><td headers="hd_h_hgc.T.molecular_genetic_testing_used_in_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a>&#x000a0;<sup>5</sup></td><td headers="hd_h_hgc.T.molecular_genetic_testing_used_in_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">4%&#x000a0;<sup>6</sup></td></tr><tr><td headers="hd_h_hgc.T.molecular_genetic_testing_used_in_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Unknown&#x000a0;<sup>7</sup></td><td headers="hd_h_hgc.T.molecular_genetic_testing_used_in_1_1_1_2 hd_h_hgc.T.molecular_genetic_testing_used_in_1_1_1_3" colspan="2" rowspan="1" style="text-align:left;vertical-align:middle;">NA</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt>1. </dt><dd><div id="hgc.TF.1.1"><p class="no_margin">See <a href="/books/n/gene/spg17/#spg17.molgen.TA">Table A. Genes and Databases</a> for <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> and protein.</p></div></dd><dt>2. </dt><dd><div id="hgc.TF.1.2"><p class="no_margin">See <a href="#hgc.Molecular_Genetics">Molecular Genetics</a> for information on allelic variants detected in this <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>.</p></div></dd><dt>3. </dt><dd><div id="hgc.TF.1.3"><p class="no_margin">Sequence analysis detects variants that are benign, likely benign, of <a class="def" href="/books/n/gene/glossary/def-item/uncertain-significance/">uncertain significance</a>, likely pathogenic, or pathogenic. Pathogenic variants may include small intragenic deletions/insertions and <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a>, <a class="def" href="/books/n/gene/glossary/def-item/nonsense-variant/">nonsense</a>, and <a class="def" href="/books/n/gene/glossary/def-item/splice-site/">splice site</a> variants; typically, <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> or whole-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> deletions/duplications are not detected. For issues to consider in interpretation of <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> results, click <a href="/books/n/gene/app2/">here</a>.</p></div></dd><dt>4. </dt><dd><div id="hgc.TF.1.4"><p class="no_margin"><a class="bk_pop" href="#hgc.REF.oliveira.2006.21">Oliveira et al [2006]</a>, <a class="bk_pop" href="#hgc.REF.kaurah.2007.2360">Kaurah et al [2007]</a></p></div></dd><dt>5. </dt><dd><div id="hgc.TF.1.5"><p class="no_margin">Gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a> detects intragenic deletions or duplications. Methods used may include: <a class="def" href="/books/n/gene/glossary/def-item/quantitative-pcr/">quantitative PCR</a>, long-range PCR, multiplex ligation-dependent probe amplification (MLPA), and a <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>-targeted microarray designed to detect single-<a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> deletions or duplications.</p></div></dd><dt>6. </dt><dd><div id="hgc.TF.1.6"><p class="no_margin">6.5% of individuals with HDGC who do not have a <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> identified on <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> [<a class="bk_pop" href="#hgc.REF.oliveira.2009.1545">Oliveira et al 2009</a>]</p></div></dd><dt>7. </dt><dd><div id="hgc.TF.1.7"><p class="no_margin">Since 50%-70% of families with HDGC reported to date have no identifiable <i>CDH1</i> <a class="def" href="/books/n/gene/glossary/def-item/germline/">germline</a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>, it is likely that some of these families may have pathogenic variants in other unidentified HDGC-susceptibility genes. Although candidate genes have been analyzed, no pathogenic variants have been identified.</p></div></dd></dl></div></div></div></div></div><div id="hgc.Clinical_Characteristics"><h2 id="_hgc_Clinical_Characteristics_">Clinical Characteristics</h2><div id="hgc.Clinical_Description"><h3>Clinical Description</h3><p><b>Age of onset.</b> The average age of onset of hereditary diffuse gastric cancer (HDGC) is 38 years (range: 14-69 years). The majority of the gastric cancers occur before age 40 years. The age of onset is variable both between and within families [<a class="bk_pop" href="#hgc.REF.gayther.1998.4086">Gayther et al 1998</a>, <a class="bk_pop" href="#hgc.REF.guilford.1998.402">Guilford et al 1998</a>]. For age-related risks of developing cancer, see <a href="#hgc.Penetrance">Penetrance</a>.</p><p><b>Symptoms</b> are nonspecific in the early stages of the disease and consequently tend to be dismissed both by <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals and by physicians. By the time specific symptoms appear, affected individuals are in an advanced stage of the disease [<a class="bk_pop" href="#hgc.REF.wanebo.1993.583">Wanebo et al 1993</a>]. Symptoms in the late stage may include abdominal pain, nausea, vomiting, dysphagia, postprandial fullness, loss of appetite, and weight loss. Late in the course of stomach cancer, a palpable mass may be present.</p><p>Tumor spread or metastasis may lead to an enlarged liver, jaundice, ascites, skin nodules, and fractures.</p><p><b>Other cancers</b> reported in family members include:</p><ul><li class="half_rhythm"><div class="half_rhythm"><b>Lobular breast cancer (LBC).</b> Females with a <i>CDH1</i> <a class="def" href="/books/n/gene/glossary/def-item/germline/">germline</a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> are at an increased lifetime risk (42% [95% confidence interval: 23%-68%]) for LBC [<a class="bk_pop" href="#hgc.REF.hansford.2015.23">Hansford et al 2015</a>]. The average age of onset for breast cancer is 53 years [<a class="bk_pop" href="#hgc.REF.pharoah.2001.1348">Pharoah et al 2001</a>].</div><div class="half_rhythm">In a study of 318 women who had a personal and family history of LBC but no family history of DGC, <a class="bk_pop" href="#hgc.REF.schrader.2011.64">Schrader et al [2011]</a> found that 1.3% had a <i>CDH1</i> <a class="def" href="/books/n/gene/glossary/def-item/germline/">germline</a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>.</div></li><li class="half_rhythm"><div class="half_rhythm"><b>Colorectal cancer</b> [<a class="bk_pop" href="#hgc.REF.richards.1999.607">Richards et al 1999</a>, <a class="bk_pop" href="#hgc.REF.oliveira.2002.510">Oliveira et al 2002</a>, <a class="bk_pop" href="#hgc.REF.brookswilson.2004.508">Brooks-Wilson et al 2004</a>]. There is no direct evidence that colorectal cancer is part of the spectrum of cancers associated with <i>CDH1</i> <a class="def" href="/books/n/gene/glossary/def-item/germline/">germline</a> pathogenic variants. Therefore, these families need to be counseled accordingly on a case-by-case basis. In families where there is a clustering of colon cancer and a <i>CDH1</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>, it is imperative to obtain as much clinical and pathologic information as possible on all individuals who have colon cancer.</div></li></ul><p><b>Survival.</b> When <a class="def" href="/books/n/gene/glossary/def-item/sporadic/">sporadic</a> (i.e., non-hereditary) diffuse gastric cancer is detected early (i.e., before it has invaded the stomach wall), the five-year survival rate can be greater than 90%. The five-year survival rate drops below 30% when the diagnosis is made at a late stage [<a class="bk_pop" href="#hgc.REF.stiekema.2013.686">Stiekema et al 2013</a>].</p><p>If gastric cancer is detected early and resected, the five-year survival rate is 90%. Because early detection of DGC is difficult, survival of individuals with <i>CDH1</i> pathogenic variants is believed to be the same as in individuals with <a class="def" href="/books/n/gene/glossary/def-item/sporadic/">sporadic</a> DGC. Therefore, in individuals with a <i>CDH1</i> <a class="def" href="/books/n/gene/glossary/def-item/germline/">germline</a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>, clinical management options include prophylactic gastrectomy and an intensive regimen of endoscopic surveillance.</p><p>Apart from the two of 17 individuals who had prophylactic gastrectomy and previous <i>Helicobacter pylori</i> infection on serologic testing [<a class="bk_pop" href="#hgc.REF.blair.2006.262">Blair et al 2006</a>], there is no evidence of increased rates of <i>H pylori</i> infection associated with the microscopic DGCs in the prophylactic gastrectomy specimens of individuals with a <a class="def" href="/books/n/gene/glossary/def-item/germline/">germline</a> <i>CDH1</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>.</p><p><b>Pathology.</b> In DGC, loss of the E-cadherin protein causes the individual tumor cells to grow and invade neighboring structures. The individual malignant cells infiltrate and spread under histologically normal-looking mucosa causing widespread thickening and rigidity of the gastric wall, a phenomenon known as <i>linitis plastica</i> [<a class="bk_pop" href="#hgc.REF.mccoll.2006.687">McColl 2006</a>]. No tumor mass is formed, unlike that of the intestinal type. The malignant cells have a distinctive signet ring appearance, which is caused by an accumulation of intracellular mucin that pushes the nucleus to one side. A clearly defined preneoplastic lesion is not seen in DGC. A progression model for DGC developed from studying prophylactic total gastrectomy (PTG) specimens from individuals with a <a class="def" href="/books/n/gene/glossary/def-item/germline/">germline</a> <i>CDH1</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> describes <a class="def" href="/books/n/gene/glossary/def-item/isolated/">isolated</a> neoplastic signet ring cells at the base of the glands and pagetoid spread of signet ring cells below the preserved epithelium of glands/foveolae into the stroma [<a class="bk_pop" href="#hgc.REF.carneiro.2004.681">Carneiro et al 2004</a>].</p></div><div id="hgc.GenotypePhenotype_Correlations"><h3>Genotype-Phenotype Correlations</h3><p>No <a class="def" href="/books/n/gene/glossary/def-item/genotype-phenotype-correlations/">genotype-phenotype correlations</a> have been reported to date.</p></div><div id="hgc.Penetrance"><h3>Penetrance</h3><p>The <a class="def" href="/books/n/gene/glossary/def-item/penetrance/">penetrance</a> of HDGC is incomplete. A recent study that included 75 families with <a class="def" href="/books/n/gene/glossary/def-item/germline/">germline</a> <i>CDH1</i> pathogenic variants found that by age 80 years, the cumulative incidence of gastric cancer was 70% (95% CI, 59%-80%) for males and 56% (95% CI, 44%-69%) for females, and the risk of breast cancer for females was 42% (95% CI, 23%-68%) [<a class="bk_pop" href="#hgc.REF.hansford.2015.23">Hansford et al 2015</a>].</p></div><div id="hgc.Prevalence"><h3>Prevalence</h3><p>The worldwide incidence of gastric cancer has been falling steadily since the 1970s with the phenomenon being most noticeable in developed countries [<a href="http://gco.iarc.fr/databases.php" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">GLOBOCAN</a>]. Given that the incidence of gastric cancer varies by geographic region, the percentage of individuals with gastric cancer who have a <a class="def" href="/books/n/gene/glossary/def-item/germline/">germline</a> <i>CDH1</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> identified ranges from 1% to 3% [<a class="bk_pop" href="#hgc.REF.corso.2012.177">Corso et al 2012</a>].</p></div></div><div id="hgc.Genetically_Related_Allelic_Disorder"><h2 id="_hgc_Genetically_Related_Allelic_Disorder_">Genetically Related (Allelic) Disorders</h2><p>No phenotypes other than those discussed in this <i>GeneReview</i> are known to be associated with <a class="def" href="/books/n/gene/glossary/def-item/germline/">germline</a> pathogenic variants in <i>CDH1</i>.</p><p>The loss of E-cadherin protein expression in <a class="def" href="/books/n/gene/glossary/def-item/sporadic/">sporadic</a> diffuse gastric and lobular breast tumors is associated with somatic <i>CDH1</i> single-nucleotide variants, <a class="def" href="/books/n/gene/glossary/def-item/loss-of-heterozygosity/">loss of heterozygosity</a>, and promoter hypermethylation in the tumors [<a class="bk_pop" href="#hgc.REF.becker.1994.3845">Becker et al 1994</a>, <a class="bk_pop" href="#hgc.REF.oda.1994.1858">Oda et al 1994</a>, <a class="bk_pop" href="#hgc.REF.day.1999.9656">Day et al 1999</a>, <a class="bk_pop" href="#hgc.REF.anastasiadis.2000.1319">Anastasiadis &#x00026; Reynolds 2000</a>, <a class="bk_pop" href="#hgc.REF.tamura.2000.569">Tamura et al 2000</a>, <a class="bk_pop" href="#hgc.REF.kallakury.2001.2786">Kallakury et al 2001</a>, <a class="bk_pop" href="#hgc.REF.machado.2001.1525">Machado et al 2001</a>].</p></div><div id="hgc.Differential_Diagnosis"><h2 id="_hgc_Differential_Diagnosis_">Differential Diagnosis</h2><p>An estimated 5%-10% of all gastric cancer is thought to be <a class="def" href="/books/n/gene/glossary/def-item/familial/">familial</a> [<a class="bk_pop" href="#hgc.REF.zanghieri.1990.2047">Zanghieri et al 1990</a>, <a class="bk_pop" href="#hgc.REF.la_vecchia.1992.50">La Vecchia et al 1992</a>]. Familial gastric cancer is both clinically and genetically heterogeneous.</p><p>Intestinal-type gastric cancer (IGC) arises from a precursor lesion, intestinal metaplasia, which forms a large protruded, ulcerated, or infiltrative lesion in the stomach. Histologically IGC is composed of tubular or glandular formations of variable differentiation that resemble adenocarcinomas of the intestinal tract. In contrast to diffuse gastric cancer (DGC), E-cadherin is present. IGC is more common than DGC, although the incidence of IGC appears to be declining [<a class="bk_pop" href="#hgc.REF.ajani.2010.378">Ajani et al 2010</a>]. Risk factors for IGC include chronic gastric mucosal infection with <i>H pylori</i> [<a class="bk_pop" href="#hgc.REF.uemura.2001.784">Uemura et al 2001</a>, <a class="bk_pop" href="#hgc.REF.suerbaum.2002.1175">Suerbaum &#x00026; Michetti 2002</a>]; smoking; a diet high in nitrites, salt, and smoked or pickled foods and low in fruit and vegetables; age; and male gender. Variants in <i>TNF</i> and <i>IFNGR1</i> can significantly increase the risk for gastric cancer, particularly in those infected with virulent strains of <i>H pylori</i> [<a class="bk_pop" href="#hgc.REF.canedo.2008.1504">Canedo et al 2008</a>].</p><div id="hgc.Other_Cancer_Predisposition_Syndrome"><h3>Other Cancer Predisposition Syndromes</h3><p>Gastric cancer is seen in several other <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> cancer predisposition syndromes, including Lynch syndrome (<a href="/books/n/gene/hnpcc/">hereditary non-polyposis colorectal cancer</a>), <a href="/books/n/gene/li-fraumeni/">Li-Fraumeni syndrome</a>, <a href="/books/n/gene/fap/">familial adenomatous polyposis</a>, <a href="/books/n/gene/pjs/">Peutz-Jeghers syndrome</a>, and Cowden syndrome (one of the <a href="/books/n/gene/phts/"><i>PTEN</i> hamartoma tumor syndrome</a> phenotypes).</p><p><a href="/books/n/gene/hnpcc/"><b>Lynch syndrome</b></a><b>,</b> which is associated with <a class="def" href="/books/n/gene/glossary/def-item/germline/">germline</a> pathogenic variants in <a class="def" href="/books/n/gene/glossary/def-item/mismatch-repair/">mismatch repair</a> genes or <i>EPCAM</i>, predisposes heterozygotes to colorectal and other cancers. Gastric cancer is the third most common cancer in these individuals. IGC is the predominant subtype in Lynch syndrome [<a class="bk_pop" href="#hgc.REF.lynch.2005.114">Lynch et al 2005</a>, <a class="bk_pop" href="#hgc.REF.capelle.2010.487">Capelle et al 2010</a>]. Microsatellite instability (MSI) was observed in approximately 15% of gastric cancers from individuals in Florence, Italy, an area with high gastric cancer risk [<a class="bk_pop" href="#hgc.REF.derrico.2009.461">D'Errico et al 2009</a>]. Gastric cancers with high MSI tend to occur in the antrum of the stomach, be of the intestinal type, and have better survival rates [<a class="bk_pop" href="#hgc.REF.falchetti.2008.925">Falchetti et al 2008</a>].</p><p><a href="/books/n/gene/fap/"><b>Familial adenomatous polyposis</b></a>
<b>(FAP)</b> is caused by <a class="def" href="/books/n/gene/glossary/def-item/germline/">germline</a> pathogenic variants in <i>APC</i>. Gastric cancer has been seen in 0.6% of persons with FAP in Western populations [<a class="bk_pop" href="#hgc.REF.jagelman.1988.1149">Jagelman et al 1988</a>]. The incidence of gastric cancer is significantly higher in individuals with FAP in the East Asian population [<a class="bk_pop" href="#hgc.REF.yamaguchi.2016.310">Yamaguchi et al 2016</a>].</p><p><a href="/books/n/gene/li-fraumeni/"><b>Li-Fraumeni syndrome</b></a>
<b>(LFS).</b> Cancers in LFS are caused by pathogenic variants in <i>TP53</i>. <i>CHEK2</i> and <i>CDKN2A</i>, which are genes in the <i>TP53</i> pathway, may be LFS candidate genes; however, further confirmation of this is needed [<a class="bk_pop" href="#hgc.REF.olivier.2003.6643">Olivier et al 2003</a>, <a class="bk_pop" href="#hgc.REF.malkin.2011.475">Malkin 2011</a>]. Both DGC and IGC are observed [<a class="bk_pop" href="#hgc.REF.keller.2004.e89">Keller et al 2004</a>, <a class="bk_pop" href="#hgc.REF.oliveira.2004.1897">Oliveira et al 2004</a>].</p><p><a href="/books/n/gene/brca1/"><b><i>BRCA1</i> and <i>BRCA2</i> hereditary breast and ovarian cancer</b></a><b>.</b> Increased risk for gastric cancer has been associated with pathogenic variants in <i>BRCA1</i> [<a class="bk_pop" href="#hgc.REF.brose.2002.1365">Brose et al 2002</a>, <a class="bk_pop" href="#hgc.REF.friedenson.2005.60">Friedenson 2005</a>] and <i>BRCA2</i> [<a class="bk_pop" href="#hgc.REF.breast_cancer_linkage_consortium.1999.1310">Breast Cancer Linkage Consortium 1999</a>, <a class="bk_pop" href="#hgc.REF.risch.2001.700">Risch et al 2001</a>]. Gastric cancer occurs in 5.7% of families with the <i>BRCA2</i> 6174delT <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> [<a class="bk_pop" href="#hgc.REF.figer.2001.478">Figer et al 2001</a>]. <a class="bk_pop" href="#hgc.REF.jakubowska.2002.888">Jakubowska et al [2002]</a> found that in 7% of individuals with gastric cancer a <i>BRCA2</i> pathogenic variant may be the underlying genetic cause, although the histopathology of the gastric cancer was not reported. Testing by multigene panels has identified <i>BRCA1</i> and <i>BRCA2</i> pathogenic variants in a number of individuals with diffuse gastric cancer and a family history of breast cancer [<a class="bk_pop" href="#hgc.REF.hansford.2015.23">Hansford et al 2015</a>, <a class="bk_pop" href="#hgc.REF.sahasrabudhe.2017.983">Sahasrabudhe et al 2017</a>, <a class="bk_pop" href="#hgc.REF.slavin.2017.111">Slavin et al 2017</a>].</p><p><a href="/books/n/gene/carney/"><b>Carney complex</b></a><b>.</b> A rare gastric lesion, gastric gastrointestinal stromal tumor, previously known as gastric epitheliod leiomyosarcoma, is found in individuals with Carney complex [<a class="bk_pop" href="#hgc.REF.carney.1977.1517">Carney et al 1977</a>]. Pathogenic variants in <i>PRKAR1A</i> are causative.</p><p><b>Carney-Stratakis syndrome</b> (OMIM <a href="http://omim.org/entry/606864" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">606864</a>). Gastric stromal sarcomas were observed in 12 individuals with this disorder who had paraganglioma, gastric stromal sarcoma, or both [<a class="bk_pop" href="#hgc.REF.carney.2002.132">Carney &#x00026; Stratakis 2002</a>]. Germline pathogenic variants in <i>SDHB</i>, <i>SDHC</i>, and <i>SDHD</i> are causative [<a class="bk_pop" href="#hgc.REF.pasini.2008.79">Pasini et al 2008</a>]. Inheritance is <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a>.</p><p><b>Gastric adenocarcinoma and proximal polyposis of the stomach (GAPPS)</b> is a recently identified <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> fundic gastric polyposis syndrome with areas of dysplasia or intestinal-type gastric adenocarcinoma that are restricted to the proximal stomach. Affected individuals are at increased risk for gastric cancer, but there is no evidence of colorectal or duodenal polyposis [<a class="bk_pop" href="#hgc.REF.worthley.2012.774">Worthley et al 2012</a>]. Heterozygous <a class="def" href="/books/n/gene/glossary/def-item/germline/">germline</a> pathogenic variants in the promoter 1B of <i>APC</i> are causative [<a class="bk_pop" href="#hgc.REF.li.2016.830">Li et al 2016</a>, <a class="bk_pop" href="#hgc.REF.repak.2016.718">Repak et al 2016</a>, <a class="bk_pop" href="#hgc.REF.beer.2017.1131">Beer et al 2017</a>].</p></div></div><div id="hgc.Management"><h2 id="_hgc_Management_">Management</h2><p>The IGCLC has updated consensus guidelines for clinical management of individuals with a <i>CDH1</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> [<a class="bk_pop" href="#hgc.REF.van_der_post.2015.361">van der Post et al 2015</a>] (see <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4453626/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">full text</a> and <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4453626/figure/JMEDGENET2015103094F1/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Figure 1</a> therein).</p><div id="hgc.Evaluations_Following_Initial_Diagno"><h3>Evaluations Following Initial Diagnosis</h3><p>To establish the extent of disease and needs in an individual diagnosed with hereditary diffuse gastric cancer, the following evaluations are recommended:</p><ul><li class="half_rhythm"><div>Baseline endoscopy to look for macroscopic tumor [<a class="bk_pop" href="#hgc.REF.van_der_post.2015.361">van der Post et al 2015</a>]</div></li><li class="half_rhythm"><div>Evaluation of <i>CDH1</i> heterozygotes for <i>H pylori</i> infection given its ability to induce promoter hypermethylation of <i>CDH1</i> and its role in gastric cancer carcinogenesis</div></li><li class="half_rhythm"><div>Clinical breast examination and mammography in females</div></li><li class="half_rhythm"><div>Consultation with a clinical geneticist and/or genetic counselor</div></li></ul></div><div id="hgc.Treatment_of_Manifestations"><h3>Treatment of Manifestations</h3><p>Care by a multidisciplinary team comprising those with expertise in clinical genetics, gastric surgery, gastroenterology, pathology, and nutrition is recommended. See <a class="bk_pop" href="#hgc.REF.fitzgerald.2010.436">Fitzgerald et al [2010]</a> (<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4453626/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">full text</a>) and <a class="bk_pop" href="#hgc.REF.van_der_post.2015.361">van der Post et al [2015]</a> (<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4453626/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">full text</a>).</p><p><b>Diffuse gastric cancer</b></p><ul><li class="half_rhythm"><div>Total gastrectomy is recommended [<a class="bk_pop" href="#hgc.REF.fitzgerald.2010.436">Fitzgerald et al 2010</a>, <a class="bk_pop" href="#hgc.REF.van_der_post.2015.361">van der Post et al 2015</a>]. Studies have shown that surgery alone is less than satisfactory, with cure rates approaching only 40%.</div></li><li class="half_rhythm"><div>Adjuvant therapy. Three large, randomized controlled trials showed the survival benefit of adjuvant therapy over surgery alone [<a class="bk_pop" href="#hgc.REF.macdonald.2000">Macdonald et al 2000</a>, <a class="bk_pop" href="#hgc.REF.cunningham.2006.11">Cunningham et al 2006</a>, <a class="bk_pop" href="#hgc.REF.sakuramoto.2007.1810">Sakuramoto et al 2007</a>]. Numerous randomized clinical trials have failed to show consistent survival benefits from adjuvant radiation therapy or chemotherapy alone in the treatment of gastric cancer.</div></li><li class="half_rhythm"><div><i>H pylori</i> infection (if present) is treated in the standard manner.</div></li></ul><p><b>Lobular breast cancer.</b> The treatment of breast cancer in individuals with <i>CDH1</i>-related breast cancer is similar to that in <a class="def" href="/books/n/gene/glossary/def-item/sporadic/">sporadic</a> forms of lobular breast cancer [<a href="https://www.nccn.org/professionals/physician_gls/default.aspx" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">National Comprehensive Cancer Network Guidelines</a>].</p></div><div id="hgc.Prevention_of_Primary_Manifestations"><h3>Prevention of Primary Manifestations</h3><div id="hgc.Heterozygotes_for_a_Germline_CDH1_Pa"><h4>Heterozygotes for a Germline <i>CDH1</i> Pathogenic Variant</h4><p><b>Diffuse gastric cancer.</b> Prophylactic total gastrectomy (PTG) is recommended rather than endoscopic surveillance due to the observation of early gastric cancers in PTG samples from individuals with a <a class="def" href="/books/n/gene/glossary/def-item/germline/">germline</a> <i>CDH1</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> [<a class="bk_pop" href="#hgc.REF.norton.2007.873">Norton et al 2007</a>]. PTG involves D-2 dissection and Roux-en-Y esophagojejunostomy and obtaining proximal margins to ensure removal of the gastric mucosa [<a class="bk_pop" href="#hgc.REF.norton.2007.873">Norton et al 2007</a>]. A multidisciplinary team including a surgeon, gastroenterologist, and dietician should provide preoperative and postoperative care for an individual undergoing PTG. The multidisciplinary team members can counsel candidates for PTG on the risks and benefits of the surgery. In making the decision to undergo PTG, the <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual and his/her physicians should consider the following:</p><ul><li class="half_rhythm"><div>In a young, healthy individual, the risk of mortality with PTG in an experienced surgeon's hands is less than 1% [<a class="bk_pop" href="#hgc.REF.lynch.2005.114">Lynch et al 2005</a>].</div></li><li class="half_rhythm"><div>The morbidity from PTG is 100% [<a class="bk_pop" href="#hgc.REF.worster.2014.87">Worster et al 2014</a>, <a class="bk_pop" href="#hgc.REF.muir.2016.1950">Muir et al 2016</a>]. All individuals have immediate as well as long-term complications including rapid intestinal transit, dumping syndrome, diarrhea, eating habit alterations, and weight loss [<a class="bk_pop" href="#hgc.REF.caldas.1999.873">Caldas et al 1999</a>, <a class="bk_pop" href="#hgc.REF.lewis.2001.612">Lewis et al 2001</a>]. The risk for malabsorption increases, including an increased incidence of osteoporosis, osteomalacia, and malnutrition.</div></li><li class="half_rhythm"><div>Gastric cancer is associated with age-specific risks: due to nutritional implications, PTG is not generally recommended until the individual's growth period is complete. In families with early-onset gastric cancer, PTG should be considered on a case-by-case basis [<a class="bk_pop" href="#hgc.REF.blair.2006.262">Blair et al 2006</a>]. In these individuals, regular endoscopic screening may be begun prior to the consideration of PTG.</div></li><li class="half_rhythm"><div>Individuals with a <i>CDH1</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> are at risk for extragastric cancers (e.g., lobular breast cancer, colorectal cancer) and should follow screening recommendations for these cancers.</div></li></ul><p><b>Breast cancer.</b> Referral to a high-risk breast clinic is recommended. Prophylactic mastectomy may be considered in women <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> for a <i>CDH1</i> <a class="def" href="/books/n/gene/glossary/def-item/germline/">germline</a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>. The authors are aware of a very limited number of women who have undergone prophylactic mastectomy for this reason [<a class="bk_pop" href="#hgc.REF.brandberg.2008.3943">Brandberg et al 2008</a>].</p></div></div><div id="hgc.Prevention_of_Secondary_Complication"><h3>Prevention of Secondary Complications</h3><p>A multidisciplinary team including a surgeon, gastroenterologist, and dietician should provide postoperative care for an individual undergoing PTG (see <a href="#hgc.Prevention_of_Primary_Manifestations">Prevention of Primary Manifestations</a>).</p></div><div id="hgc.Surveillance"><h3>Surveillance</h3><p>See <a class="bk_pop" href="#hgc.REF.fitzgerald.2010.436">Fitzgerald et al [2010]</a> (<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4453626/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">full text</a>) and <a class="bk_pop" href="#hgc.REF.van_der_post.2015.361">van der Post et al [2015]</a> (<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4453626/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">full text</a>).</p><div id="hgc.Gastric_Cancer"><h4>Gastric Cancer</h4><p>The optimal surveillance of individuals with a <i>CDH1</i> <a class="def" href="/books/n/gene/glossary/def-item/germline/">germline</a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> is controversial because of the unproven benefit of screening.</p><p><b>Endoscopy</b> permits direct inspection and biopsy of suspicious areas; however, diffuse gastric cancer is difficult to detect at an early, treatable stage because the lesions tend to spread in the submucosa rather than as exophytic masses. The submucosal lesions are difficult to identify; an additional challenge is sampling bias in a macroscopically normal-appearing gastric mucosa. Therefore, diffuse gastric cancer is often not detected until it reaches an advanced, incurable stage.</p><p>At-risk individuals who are not ready to undergo PTG should be screened using the Cambridge protocol [<a class="bk_pop" href="#hgc.REF.barber.2008.286">Barber et al 2008</a>]:</p><ul><li class="half_rhythm"><div>Detailed 30-minute upper endoscopy every six to 12 months with multiple random biopsies and biopsies of subtle lesions</div></li><li class="half_rhythm"><div>Screening beginning five to ten years prior to the earliest cancer diagnosis in the family</div></li></ul><p><a class="bk_pop" href="#hgc.REF.mi.2018.408">Mi et al [2018]</a> evaluated the utility of endoscopic surveillance in individuals with an identified <i>CDH1</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> who were delaying PTG and a group with clinically diagnosed HDGC but no identified <i>CDH1</i> pathogenic variant. The authors used autofluorescence imaging and narrow-band imaging with random biopsies; surveillance was performed by the same group of specialists on all individuals. Individuals with a <i>CDH1</i> pathogenic variant were found to have a high yield of signet ring cell carcinoma foci on their first endoscopy (63.6%) compared to the latter group (9.7%), underscoring the importance of baseline endoscopy in perhaps staging invasive disease before gastrectomy in individuals with a <i>CDH1</i> pathogenic variant.</p><p><b>Several other screening modalities for diffuse gastric cancer</b> are being tested.</p><p><b>Chromoendoscopy,</b> using indigo-carmine staining, has been shown to improve the detection rate of early gastric cancer [<a class="bk_pop" href="#hgc.REF.stepp.1998.379">Stepp et al 1998</a>, <a class="bk_pop" href="#hgc.REF.fennerty.1999.423">Fennerty 1999</a>]. <a class="bk_pop" href="#hgc.REF.charlton.2004.814">Charlton et al [2004]</a> studied six stomachs removed prophylactically after macroscopically normal gastric endoscopies. A pH-sensitive Congo red dye followed by pentagastric stimulation revealed signet ring foci that were five times more prevalent in the transitional zone of the distal stomach, a finding in contrast with other studies [<a class="bk_pop" href="#hgc.REF.carneiro.2004.681">Carneiro et al 2004</a>]. The transitional zone occupies less than 10% of the stomach and lacks gastric-secreting G cells. The authors suggest that chromoendoscopy using Congo red dye and pentagastric stimulation may highlight this area during endoscopy and thus increase the chances of detecting cancer foci. Further research is needed to evaluate this possibility.</p><p>The same group of investigators reported a year later on a follow up of 99 surveillance endoscopies over five years [<a class="bk_pop" href="#hgc.REF.shaw.2005.461">Shaw et al 2005</a>]:</p><ul><li class="half_rhythm"><div>69 of 99 (70%) endoscopies were normal.</div></li><li class="half_rhythm"><div>23 lesions with signet ring cell cancer were identified in ten individuals.</div></li><li class="half_rhythm"><div>The Congo red/methylene blue dye detected foci between 4 and 10 mm, not less than 4 mm.</div></li></ul><p>Note: Congo red is no longer available for this use due to concerns over toxicity of the dye.</p><p><a class="bk_pop" href="#hgc.REF.h_neburg.2016.e1305">H&#x000fc;neburg et al [2016]</a> performed endoscopic detection on seven individuals with <i>CDH1</i> pathogenic variants by using high-resolution white light endoscopy and pan gastric chromoendoscopy with indigo carmine combined with targeted and random biopsies. All individuals were scheduled for this presurgical procedure. Using the Cambridge protocol, only a single focus of signet ring cell cancer (14%) was detected during the random biopsies. Given the small numbers in these series and the conflicting results, these findings need to be evaluated in more individuals with a <i>CDH1</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>.</p><p><b>Endoscopic ultrasound examination</b> is important in the detection and staging of gastrointestinal cancers [<a class="bk_pop" href="#hgc.REF.pfau.2002.21">Pfau &#x00026; Chak 2002</a>], but is not believed to be useful in detecting precursor lesions [<a class="bk_pop" href="#hgc.REF.fitzgerald.2004.775">Fitzgerald &#x00026; Caldas 2004</a>].</p><p><b>Other</b> tools in use include PET scan [<a class="bk_pop" href="#hgc.REF.van_kouwen.2004.85">van Kouwen et al 2004</a>], endoscopic ultrasound, stool for guaiac, abdominal CT, and multiple random stomach biopsies [<a class="bk_pop" href="#hgc.REF.barber.2008.286">Barber et al 2008</a>]. However, none of these reliably detects DGC, as demonstrated by the finding &#x02013; one week after a number of these screening investigations were performed &#x02013; of multiple small cancer foci in six of six gastrectomy specimens from individuals who were <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> for a <i>CDH1</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> [<a class="bk_pop" href="#hgc.REF.norton.2007.873">Norton et al 2007</a>].</p></div><div id="hgc.Lobular_Breast_Cancer_LBC"><h4>Lobular Breast Cancer (LBC)</h4><p>Currently the data on women with <a class="def" href="/books/n/gene/glossary/def-item/germline/">germline</a> <i>CDH1</i> pathogenic variants and lobular breast cancer are insufficient to determine the best screening strategies. Recommendations for LBC risk management in <i>CDH1</i> heterozygotes or at-risk women are based on recommendations for women with a <i>BRCA1</i> or <i>BRCA2</i> germline <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> (see <a href="/books/n/gene/brca1/"><i>BRCA1</i> and <i>BRCA2</i> Hereditary Breast and Ovarian Cancer</a>) including:</p><ul><li class="half_rhythm"><div>Monthly breast self-examinations starting at age 20</div></li><li class="half_rhythm"><div>Clinical breast examinations every six months starting at age 30</div></li><li class="half_rhythm"><div>Referral to a high-risk breast-screening program if possible. Given the low <a class="def" href="/books/n/gene/glossary/def-item/sensitivity/">sensitivity</a> of detecting lobular breast cancer by mammography, bilateral breast MRI examination should be performed in females with a <i>CDH1</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>. Annual breast MRI examination starting at age 30 in women with a <i>CDH1</i> pathogenic variant is recommended.</div></li></ul></div><div id="hgc.Colon_Cancer"><h4>Colon Cancer</h4><p>Although evidence is insufficient to conclude that colon cancer is a manifestation of HDGC, it is prudent to recommend colonoscopy every three to five years beginning at age 40 years or ten years prior to the youngest age at diagnosis of colon cancer in families in which both DGC and colon cancer have occurred [<a class="bk_pop" href="#hgc.REF.fitzgerald.2010.436">Fitzgerald et al 2010</a>, <a class="bk_pop" href="#hgc.REF.van_der_post.2015.361">van der Post et al 2015</a>].</p></div></div><div id="hgc.Evaluation_of_Relatives_at_Risk"><h3>Evaluation of Relatives at Risk</h3><p>It is appropriate to offer <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> to at-risk relatives if the <i>CDH1</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> is identified in an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> family member so that morbidity and mortality can be reduced by early diagnosis and treatment.</p><p>See <a href="#hgc.Related_Genetic_Counseling_Issues">Genetic Counseling</a>, <b>Predictive testing in minors</b> for discussion of issues related to testing of this population and issues related to testing of at-risk relatives for <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> purposes.</p></div><div id="hgc.Pregnancy_Management"><h3>Pregnancy Management</h3><p>Evidence shows that pregnancy after PTG can have healthy and normal outcomes. <a class="bk_pop" href="#hgc.REF.kaurah.2010.331">Kaurah et al [2010]</a> discussed six healthy pregnancies and infants born to four women after total gastrectomy. However, it is important that pregnant women who have undergone PTG be followed closely by their physician and a dietician who is aware of their situation.</p></div><div id="hgc.Therapies_Under_Investigation"><h3>Therapies Under Investigation</h3><p>Search <a href="http://clinicaltrials.gov/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">ClinicalTrials.gov</a> in the US and <a href="http://www.clinicaltrialsregister.eu/ctr-search/search" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">EU Clinical Trials Register</a> in Europe for information on clinical studies for a wide range of diseases and conditions.</p></div></div><div id="hgc.Genetic_Counseling"><h2 id="_hgc_Genetic_Counseling_">Genetic Counseling</h2><p>
<i>Genetic counseling is the process of providing individuals and families with
information on the nature, inheritance, and implications of genetic disorders to help them
make informed medical and personal decisions. The following section deals with genetic
risk assessment and the use of family history and genetic testing to clarify genetic
status for family members. This section is not meant to address all personal, cultural, or
ethical issues that individuals may face or to substitute for consultation with a genetics
professional</i>. &#x02014;ED.</p><div id="hgc.Mode_of_Inheritance"><h3>Mode of Inheritance</h3><p>Hereditary diffuse gastric cancer (HDGC) is inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> manner.</p></div><div id="hgc.Risk_to_Family_Members"><h3>Risk to Family Members</h3><p><b>Parents of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>The majority of individuals with <i>CDH1</i>-related HDGC inherited the <i>CDH1</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> from a parent. Because of reduced <a class="def" href="/books/n/gene/glossary/def-item/penetrance/">penetrance</a>, the parent from whom the pathogenic variant was inherited may not have developed cancer.</div></li><li class="half_rhythm"><div>Alternatively, a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> with HDGC may have the disorder as the result of a <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>. <a class="bk_pop" href="#hgc.REF.shah.2012.283">Shah et al [2012]</a> described the first conclusive case of a <i>de novo</i>
<i>CDH1</i> <a class="def" href="/books/n/gene/glossary/def-item/germline/">germline</a> pathogenic variant in a family with HDGC.</div></li><li class="half_rhythm"><div>Recommendations for the evaluation of parents of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> with an apparent <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> include <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a>.</div></li><li class="half_rhythm"><div>If the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> found in the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> cannot be detected in leukocyte DNA of either parent, possible explanations include a <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> <a class="def" href="/books/n/gene/glossary/def-item/germline/">germline</a> pathogenic variant in the proband or <a class="def" href="/books/n/gene/glossary/def-item/germline-mosaicism/">germline mosaicism</a> in a parent. Though theoretically possible, no instances of germline mosaicism have been reported.</div></li><li class="half_rhythm"><div>Note: Although most individuals diagnosed with HDGC have an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> parent, the family history may appear to be negative because of failure to recognize the disorder in family members, early death of the parent before the onset of symptoms, or reduced <a class="def" href="/books/n/gene/glossary/def-item/penetrance/">penetrance</a>.</div></li></ul><p><b>Sibs of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>The risk to the sibs of the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> depends on the genetic status of the proband's parents.</div></li><li class="half_rhythm"><div>If a parent of the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> is <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> and/or has a <i>CDH1</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>, the risk to the sibs of inheriting the pathogenic variant is 50%.</div></li><li class="half_rhythm"><div>The sibs of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> with clinically unaffected parents are still at increased risk for HDGC because of the possibility of reduced <a class="def" href="/books/n/gene/glossary/def-item/penetrance/">penetrance</a> in a parent.</div></li><li class="half_rhythm"><div>If the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> cannot be detected in the DNA of either parent and biparental inheritance at the <i>CDH1</i> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> is proven by haplotype inheritance, the risk to sibs is presumed to be slightly greater than that of the general population (though still &#x0003c;1%) because of the theoretic possibility of parental <a class="def" href="/books/n/gene/glossary/def-item/germline-mosaicism/">germline mosaicism</a>.</div></li></ul><p><b>Offspring of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</b> Each child of a proband is at a 50% risk of inheriting the cancer-predisposing variant.</p><p><b>Other family members.</b> The risk to other family members depends on the status of the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>'s parents: if a parent is <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> or has a <i>CDH1</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>, his or her family members are at risk.</p></div><div id="hgc.Related_Genetic_Counseling_Issues"><h3>Related Genetic Counseling Issues</h3><p>See Management, <a href="#hgc.Evaluation_of_Relatives_at_Risk">Evaluation of Relatives at Risk</a> for information on evaluating at-risk relatives for the purpose of early diagnosis and treatment.</p><p><b>Genetic cancer risk assessment and counseling.</b> For a comprehensive description of the medical, psychosocial, and ethical ramifications of identifying at-risk individuals through cancer risk assessment with or without <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a>, see <a href="http://www.cancer.gov/about-cancer/causes-prevention/genetics/risk-assessment-pdq" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Cancer Genetics Risk Assessment and Counseling - for health professionals</a> (part of PDQ<sup>&#x000ae;</sup>, National Cancer Institute).</p><p><b>Predictive testing (i.e., testing of asymptomatic at-risk individuals)</b></p><ul><li class="half_rhythm"><div>Predictive testing for at-risk relatives is possible once the <i>CDH1</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> has been identified in an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> family member.</div></li><li class="half_rhythm"><div>Potential consequences of such testing (including but not limited to socioeconomic changes and the need for long-term follow up and evaluation arrangements for individuals with a positive test result) as well as the capabilities and limitations of predictive testing should be discussed in the context of formal <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> prior to testing.</div></li><li class="half_rhythm"><div>In 50%-70% of families with HDGC, cancer susceptibility is caused by unknown genetic factors; thus, predictive testing is not possible in these families.</div></li></ul><p><b>Predictive testing in minors (i.e., testing of asymptomatic at-risk individuals younger than age 18 years).</b> Genetic testing in individuals younger than age 18 years has always been a controversial issue. Since there have been reports of individuals younger than age 18 years who are diagnosed with HDGC [<a class="bk_pop" href="#hgc.REF.guilford.1998.402">Guilford et al 1998</a>], it has been suggested that genetic testing in individuals younger than age 18 years may be beneficial [<a class="bk_pop" href="#hgc.REF.caldas.1999.873">Caldas et al 1999</a>, <a class="bk_pop" href="#hgc.REF.fitzgerald.2010.436">Fitzgerald et al 2010</a>]. <a class="bk_pop" href="#hgc.REF.kodish.1999.390">Kodish [1999]</a> proposed the application of the following rule to the testing of minors: genetic testing should be permitted at an age no earlier than the age of first possible onset of cancer. He states that this rule tries to maximize the benefits to the child while minimizing the risks. Overall, a request from parents for testing of asymptomatic at-risk individuals younger than age 18 years requires sensitive and understanding (though rigorous) counseling for both the parents and the child. The IGCLC has agreed that genetic testing of at-risk individuals at age 16 years can be considered if the age of onset in the family is early [<a class="bk_pop" href="#hgc.REF.fitzgerald.2010.436">Fitzgerald et al 2010</a>].</p><p><b>Considerations in families with an apparent <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>.</b> When neither parent of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> with an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> condition has the pathogenic variant identified in the proband or clinical evidence of the disorder, the pathogenic variant is likely <i>de novo</i>. However, non-medical explanations including <a class="def" href="/books/n/gene/glossary/def-item/alternate-paternity/">alternate paternity</a> or maternity (e.g., with assisted reproduction) and undisclosed adoption could also be explored.</p><p><b>Family planning</b></p><ul><li class="half_rhythm"><div>The optimal time for determination of genetic risk and discussion of the availability of prenatal testing is before pregnancy.</div></li><li class="half_rhythm"><div>It is appropriate to offer <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> (including discussion of potential risks to offspring and reproductive options) to young adults who are <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> or at risk.</div></li></ul><p><b>DNA banking</b> is the storage of DNA (typically extracted from white blood cells) for possible future use. Because it is likely that testing methodology and our understanding of genes, allelic variants, and diseases will improve in the future, consideration should be given to banking DNA of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals.</p></div><div id="hgc.Prenatal_Testing_and_Preimplantation"><h3>Prenatal Testing and Preimplantation Genetic Diagnosis</h3><p>Once the <i>CDH1</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> has been identified in an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> family member, prenatal testing for a pregnancy at increased risk and <a class="def" href="/books/n/gene/glossary/def-item/preimplantation-genetic-diagnosis/">preimplantation genetic diagnosis</a> are possible.</p><p>Differences in perspective may exist among medical professionals and in families regarding the use of prenatal testing, particularly if the testing is being considered for the purpose of pregnancy termination rather than early diagnosis. While most centers would consider decisions regarding prenatal testing to be the choice of the parents, discussion of these issues is appropriate.</p></div></div><div id="hgc.Resources"><h2 id="_hgc_Resources_">Resources</h2><p>
<i>GeneReviews staff has selected the following disease-specific and/or umbrella
support organizations and/or registries for the benefit of individuals with this disorder
and their families. GeneReviews is not responsible for the information provided by other
organizations. For information on selection criteria, click <a href="/books/n/gene/app4/">here</a>.</i></p><ul><li class="half_rhythm"><div><b>My46 Trait Profile</b></div><div><a href="https://www.my46.org/trait-document?trait=Hereditary%20Diffuse%20Gastric%20Cancer&#x00026;parent=Disease%20Risk&#x00026;type=profile" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Hereditary Diffuse Gastric Cancer</a></div></li><li class="half_rhythm"><div><b>National Cancer Institute (NCI)</b></div><div>6116 Executive Boulevard</div><div>Suite 300</div><div>Bethesda MD 20892-8322</div><div><b>Phone:</b> 800-422-6237 (toll-free)</div><div><b>Email:</b> cancergovstaff@mail.nih.gov</div><div><a href="http://www.nci.nih.gov/cancertopics/types/stomach" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Stomach (Gastric) Cancer</a></div></li><li class="half_rhythm"><div><b>No Stomach For Cancer, Inc.</b></div><div>9202 Waterside Street</div><div>#203</div><div>Middleton WI 53562</div><div><b>Phone:</b> 608-335-0241</div><div><b>Email:</b> info@nostomachforcancer.org</div><div><a href="http://www.nostomachforcancer.org" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.nostomachforcancer.org</a></div></li><li class="half_rhythm"><div><b>PMP Pals</b></div><div>PO Box 6484</div><div>Salinas CA 93912</div><div><b>Phone:</b> 831-424-4545</div><div><b>Email:</b> pmppals@yahoo.com</div><div><a href="http://www.pmppals.org" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.pmppals.org</a></div></li><li class="half_rhythm"><div><b>American Cancer Society (ACS)</b></div><div>250 Williams Street Northwest</div><div>Atlanta GA 30303</div><div><b>Phone:</b> 800-227-2345 (toll-free 24/7); 866-228-4327 (toll-free 24/7 TTY)</div><div><a href="http://www.cancer.org" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.cancer.org</a></div></li><li class="half_rhythm"><div><b>CancerCare</b></div><div>275 Seventh Avenue</div><div>22nd Floor</div><div>New York NY 10001</div><div><b>Phone:</b> 800-813-4673 (toll-free); 212-712-8400 (administrative)</div><div><b>Fax:</b> 212-712-8495</div><div><b>Email:</b> info@cancercare.org</div><div><a href="http://www.cancercare.org" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.cancercare.org</a></div></li><li class="half_rhythm"><div><b>Prospective Registry of MultiPlex Testing (PROMPT)</b></div><div><i>PROMPT is an online research registry for patients and families who have undergone multiplex genetic testing and were found to have a genetic variation which may be linked to an increased risk of having cancer.</i></div><div><a href="https://connect.patientcrossroads.org/?org=prompt" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">PROMPT</a></div></li></ul></div><div id="hgc.Molecular_Genetics"><h2 id="_hgc_Molecular_Genetics_">Molecular Genetics</h2><p><i>Information in the Molecular Genetics and OMIM tables may differ from that elsewhere in the GeneReview: tables may contain more recent information. &#x02014;</i>ED.</p><div id="hgc.molgen.TA" class="table"><h3><span class="label">Table A.</span></h3><div class="caption"><p>Hereditary Diffuse Gastric Cancer: Genes and Databases</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1139/table/hgc.molgen.TA/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__hgc.molgen.TA_lrgtbl__"><table class="no_bottom_margin"><tbody><tr><th id="hd_b_hgc.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;">Gene</th><th id="hd_b_hgc.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;">Chromosome Locus</th><th id="hd_b_hgc.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;">Protein</th><th id="hd_b_hgc.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;">Locus-Specific Databases</th><th id="hd_b_hgc.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;">HGMD</th><th id="hd_b_hgc.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;">ClinVar</th></tr><tr><td headers="hd_b_hgc.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;"><a href="/gene/999" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=gene"><i>CDH1</i></a></td><td headers="hd_b_hgc.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/genome/gdv/?context=gene&#x00026;acc=999" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">16q22<wbr style="display:inline-block"></wbr>​.1</a></td><td headers="hd_b_hgc.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.uniprot.org/uniprot/P12830" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Cadherin-1</a></td><td headers="hd_b_hgc.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.lovd.nl/CDH1" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">CDH1 @ LOVD</a></td><td headers="hd_b_hgc.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.hgmd.cf.ac.uk/ac/gene.php?gene=CDH1" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">CDH1</a></td><td headers="hd_b_hgc.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=CDH1[gene]" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">CDH1</a></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div id="hgc.TFA.1"><p class="no_margin">Data are compiled from the following standard references: <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> from
<a href="http://www.genenames.org/index.html" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">HGNC</a>;
<a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> from
<a href="http://www.omim.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">OMIM</a>;
protein from <a href="http://www.uniprot.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">UniProt</a>.
For a description of databases (Locus Specific, HGMD, ClinVar) to which links are provided, click
<a href="/books/n/gene/app1/">here</a>.</p></div></dd></dl></div></div></div><div id="hgc.molgen.TB" class="table"><h3><span class="label">Table B.</span></h3><div class="caption"><p>OMIM Entries for Hereditary Diffuse Gastric Cancer (<a href="/omim/137215,192090" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">View All in OMIM</a>) </p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1139/table/hgc.molgen.TB/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__hgc.molgen.TB_lrgtbl__"><table><tbody><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/137215" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">137215</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">GASTRIC CANCER, HEREDITARY DIFFUSE; HDGC</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/192090" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">192090</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">CADHERIN 1; CDH1</td></tr></tbody></table></div></div><div id="hgc.Molecular_Pathogenesis"><h3>Molecular Pathogenesis</h3><p>E-cadherin is a transmembrane protein that is predominantly expressed at the basolateral membrane of epithelial cells, where it exerts cell-cell adhesion and invasion-suppression functions [<a class="bk_pop" href="#hgc.REF.nagar.1996.360">Nagar et al 1996</a>].</p><p>E-cadherin is one member of the cadherin family of molecules, all of which are transmembrane glycoproteins mediating calcium-dependent cell-cell adhesion [<a class="bk_pop" href="#hgc.REF.takeichi.1991.1451">Takeichi 1991</a>, <a class="bk_pop" href="#hgc.REF.berx.1995.281">Berx et al 1995</a>]. E-cadherin is critical for establishing and maintaining polarized and differentiated epithelia during development [<a class="bk_pop" href="#hgc.REF.keller.2002.229">Keller 2002</a>]. It also plays important roles in signal transduction, differentiation, <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> expression, cell motility, and inflammation. The activity of E-cadherin in cell adhesion is dependent on its association with the actin cytoskeleton via undercoat proteins called catenins (&#x003b1;-, &#x003b2;-, and &#x003b3;-) [<a class="bk_pop" href="#hgc.REF.jou.1995.5067">Jou et al 1995</a>, <a class="bk_pop" href="#hgc.REF.kallakury.2001.2786">Kallakury et al 2001</a>].</p><p>A role for E-cadherin in tumor development is well established [<a class="bk_pop" href="#hgc.REF.wijnhoven.2000.992">Wijnhoven et al 2000</a>] because many human carcinomas (e.g., skin, lung, breast, urologic, gastric, colon, pancreatic, ovarian) exhibit reduced E-cadherin expression relative to their normal cellular counterparts [<a class="bk_pop" href="#hgc.REF.giroldi.2000.31">Giroldi et al 2000</a>, <a class="bk_pop" href="#hgc.REF.karayiannakis.2001.31">Karayiannakis et al 2001</a>, <a class="bk_pop" href="#hgc.REF.tsanou.2008.3815">Tsanou et al 2008</a>, <a class="bk_pop" href="#hgc.REF.chng.2009.918">Ch'ng &#x00026; Tan 2009</a>, <a class="bk_pop" href="#hgc.REF.kuner.2009.32">Kuner et al 2009</a>]. Loss of E-cadherin expression is seen in most diffuse gastric cancers and in lobular breast cancers; expression is usually maintained in intestinal gastric cancers and ductal breast cancers [<a class="bk_pop" href="#hgc.REF.hirohashi.2000.28">Hirohashi 2000</a>].</p><p>Cells deficient in E-cadherin lose their ability to adhere to each other and consequently become invasive and metastasize [<a class="bk_pop" href="#hgc.REF.birchmeier.1995.97">Birchmeier 1995</a>, <a class="bk_pop" href="#hgc.REF.perl.1998.190">Perl et al 1998</a>]. The causal effect of E-cadherin loss or dysregulation in tumorigenesis has been demonstrated using carcinoma cell lines and transgenic models [<a class="bk_pop" href="#hgc.REF.hsu.2000.1515">Hsu et al 2000</a>]. Examination of in situ diffuse gastric cancer lesions from a prophylactic total gastrectomy specimen have shown this loss of E-cadherin to be an early initialing event that leads to invasion [<a class="bk_pop" href="#hgc.REF.humar.2007.2480">Humar et al 2007</a>].</p><p>Loss of heterozygosity is a common phenomenon seen in association with loss of expression of tumor suppressor genes [<a class="bk_pop" href="#hgc.REF.knudson.1971.820">Knudson 1971</a>]. The tumor suppressor function of E-cadherin is supported through evidence of the loss of expression of the other <i>CDH1</i> <a class="def" href="/books/n/gene/glossary/def-item/allele/">allele</a> [<a class="bk_pop" href="#hgc.REF.grady.2000.16">Grady et al 2000</a>, <a class="bk_pop" href="#hgc.REF.barber.2008.286">Barber et al 2008</a>, <a class="bk_pop" href="#hgc.REF.oliveira.2009.1545">Oliveira et al 2009</a>].</p><p><b>Gene structure.</b>
<i>CDH1</i> comprises 16 exons that span 100 kb. For a detailed summary of <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> and protein information, see <a href="/books/NBK1139/#hgc.molgen.TA">Table A</a>, <b>Gene</b>.</p><p><b>Pathogenic variants.</b> To date, more than 155 <a class="def" href="/books/n/gene/glossary/def-item/germline/">germline</a> pathogenic variants have been reported in families with hereditary diffuse gastric cancer [<a class="bk_pop" href="#hgc.REF.gayther.1998.4086">Gayther et al 1998</a>, <a class="bk_pop" href="#hgc.REF.guilford.1998.402">Guilford et al 1998</a>, <a class="bk_pop" href="#hgc.REF.richards.1999.607">Richards et al 1999</a>, <a class="bk_pop" href="#hgc.REF.yoon.1999.177">Yoon et al 1999</a>, <a class="bk_pop" href="#hgc.REF.dussaulxgarin.2001.711">Dussaulx-Garin et al 2001</a>, <a class="bk_pop" href="#hgc.REF.humar.2002.518">Humar et al 2002</a>, <a class="bk_pop" href="#hgc.REF.jonsson.2002.838">Jonsson et al 2002</a>, <a class="bk_pop" href="#hgc.REF.oliveira.2002.510">Oliveira et al 2002</a>, <a class="bk_pop" href="#hgc.REF.brookswilson.2004.508">Brooks-Wilson et al 2004</a>, <a class="bk_pop" href="#hgc.REF.keller.2004.e89">Keller et al 2004</a>, <a class="bk_pop" href="#hgc.REF.suriano.2005.5401">Suriano et al 2005</a>, <a class="bk_pop" href="#hgc.REF.frebourg.2006.138">Frebourg et al 2006</a>, <a class="bk_pop" href="#hgc.REF.rodriguezsanjuan.2006.1110">Rodriguez-Sanjuan et al 2006</a>, <a class="bk_pop" href="#hgc.REF.kaurah.2007.2360">Kaurah et al 2007</a>, <a class="bk_pop" href="#hgc.REF.masciari.2007.726">Masciari et al 2007</a>, <a class="bk_pop" href="#hgc.REF.more.2007.203">More et al 2007</a>, <a class="bk_pop" href="#hgc.REF.roviello.2007.448">Roviello et al 2007</a>, <a class="bk_pop" href="#hgc.REF.van_domselaar.2007.158">Van Domselaar et al 2007</a>, <a class="bk_pop" href="#hgc.REF.oliveira.2009.1545">Oliveira et al 2009</a>, <a class="bk_pop" href="#hgc.REF.ghaffari.2010.559">Ghaffari et al 2010</a>, <a class="bk_pop" href="#hgc.REF.mayrbaeurl.2010.306">Mayrbaeurl et al 2010</a>].</p><p>The pathogenic variants are primarily truncating, usually through frameshift variants, <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a>/<a class="def" href="/books/n/gene/glossary/def-item/intron/">intron</a> <a class="def" href="/books/n/gene/glossary/def-item/splice-site/">splice site</a> variants, and single-nucleotide variants [<a class="bk_pop" href="#hgc.REF.gayther.1998.4086">Gayther et al 1998</a>, <a class="bk_pop" href="#hgc.REF.guilford.1998.402">Guilford et al 1998</a>, <a class="bk_pop" href="#hgc.REF.richards.1999.607">Richards et al 1999</a>, <a class="bk_pop" href="#hgc.REF.humar.2002.518">Humar et al 2002</a>, <a class="bk_pop" href="#hgc.REF.oliveira.2002.510">Oliveira et al 2002</a>, <a class="bk_pop" href="#hgc.REF.brookswilson.2004.508">Brooks-Wilson et al 2004</a>].</p><p>Pathogenic <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a> variants have also been identified in some families [<a class="bk_pop" href="#hgc.REF.shinmura.1999.1127">Shinmura et al 1999</a>, <a class="bk_pop" href="#hgc.REF.yoon.1999.177">Yoon et al 1999</a>, <a class="bk_pop" href="#hgc.REF.oliveira.2002.510">Oliveira et al 2002</a>, <a class="bk_pop" href="#hgc.REF.brookswilson.2004.508">Brooks-Wilson et al 2004</a>]. The pathogenicity of missense variants can be investigated through in vitro analysis, although only on a research basis [<a class="bk_pop" href="#hgc.REF.suriano.2003.575">Suriano et al 2003</a>].</p><p>Large deletions make up approximately 4% of these variants [<a class="bk_pop" href="#hgc.REF.oliveira.2009.1545">Oliveira et al 2009</a>, <a class="bk_pop" href="#hgc.REF.yamada.2014.750">Yamada et al 2014</a>].</p><p>The pathogenic variants are distributed throughout the <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>. However, there are reports of the same <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> being found in several unrelated families [<a class="bk_pop" href="#hgc.REF.hansford.2015.23">Hansford et al 2015</a>].</p><p>A <a class="def" href="/books/n/gene/glossary/def-item/founder-variant/">founder variant</a> has been seen in four families from Newfoundland, Canada [<a class="bk_pop" href="#hgc.REF.kaurah.2007.2360">Kaurah et al 2007</a>]. The <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> <a href="/nuccore/NM_004360.3" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NM_004360.3</a>:c.2398delC (p.Arg800AlafsTer16) was confirmed by haplotype analysis in these families.</p><p>Germline pathogenic variants have been identified in several ethnic groups; <a class="def" href="/books/n/gene/glossary/def-item/germline/">germline</a> variants appear to be rare in countries in which the rates of <a class="def" href="/books/n/gene/glossary/def-item/sporadic/">sporadic</a> gastric cancer are high [<a class="bk_pop" href="#hgc.REF.hansford.2015.23">Hansford et al 2015</a>]. The reason is not known; it may be postulated that the differences in genetic backgrounds of the various ethnicities may have different effects on the viability of embryos with mutated <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> germline <i>CDH1</i> pathogenic variants.</p><p><b>Normal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> The longest transcript, <a href="/nuccore/NM_004360.3" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NM_004360.3</a>, is 4.5 kb and is translated into a 135-kd precursor polypeptide of E-cadherin. This in turn is rapidly processed to the mature 120-kd form. The mature E-cadherin protein contains three domains: the extracellular <a class="def" href="/books/n/gene/glossary/def-item/domain/">domain</a> encoded by exons 4-13, the transmembrane domain encoded by parts of exons 13 and 14, and the highly conserved cytoplasmic domain encoded by the rest of <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> 14 to exon 16.</p><ul><li class="half_rhythm"><div>The large extracellular <a class="def" href="/books/n/gene/glossary/def-item/domain/">domain</a> (N-terminal) is made up of five tandem cadherin repeats each containing about 110 amino acid residues [<a class="bk_pop" href="#hgc.REF.oliveira.2003.201">Oliveira et al 2003</a>, <a class="bk_pop" href="#hgc.REF.bryant.2004.427">Bryant &#x00026; Stow 2004</a>]. The extracellular domain homodimerizes with E-cadherin expressed in neighboring epithelial cells in a Ca<sup>2+</sup>-dependent manner, thus enabling cell-cell adhesion at the zonula adherens junctions of the homotypic neighboring cells.</div></li><li class="half_rhythm"><div>The cytoplasmic <a class="def" href="/books/n/gene/glossary/def-item/domain/">domain</a> (C-terminal) interacts with the cytoskeleton actin filaments through &#x003b1;-, &#x003b2;-, and &#x003b3;-catenins and p120<sup>ctn</sup> catenins in regulating the intracellular signaling pathways. &#x003b2;-catenin attaches to the C-terminal region of E-cadherin and then to &#x003b1;-catenin, which then binds to the F-actin microfilaments of the cytoskeleton. p120<sup>ctn</sup> binds to a juxtamembrane site of E-cadherin cytoplasmic tail [<a class="bk_pop" href="#hgc.REF.bryant.2004.427">Bryant &#x00026; Stow 2004</a>]. p120 also provides complex stability [<a class="bk_pop" href="#hgc.REF.weis.2006.35593">Weis &#x00026; Nelson 2006</a>].</div></li></ul><p>E-cadherin expression is controlled through a complex transcriptional regulation system.</p><ul><li class="half_rhythm"><div>Several transcriptional repressors such as Snail, Slug, Twist, Sip-1/ZEB-2, dEF1/ZEB-1, and E12/E47 bind to the E-box motifs in the <i>CDH1</i> promoter [<a class="bk_pop" href="#hgc.REF.conaccisorrell.2003.847">Conacci-Sorrell et al 2003</a>, <a class="bk_pop" href="#hgc.REF.nelson.2004.1483">Nelson &#x00026; Nusse 2004</a>, <a class="bk_pop" href="#hgc.REF.gloushankova.2008.742">Gloushankova 2008</a>].</div></li><li class="half_rhythm"><div>Intron 2 of <i>CDH1</i> has been implicated in the normal expression of the <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>. Intron 2, which accounts for the majority of the noncoding <a class="def" href="/books/n/gene/glossary/def-item/intronic/">intronic</a> sequences of <i>CDH1</i>, contains conserved <a class="def" href="/books/n/gene/glossary/def-item/cis/"><i>cis</i></a>-regulatory elements. <a class="bk_pop" href="#hgc.REF.stemmler.2005.965">Stemmler et al [2005]</a> performed a study in which <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> of murine <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> <a class="def" href="/books/n/gene/glossary/def-item/intron/">intron</a> 2 led to inactivation of the gene during early embryonic development.</div></li></ul><p><b>Abnormal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> See <a href="#hgc.Molecular_Pathogenesis">Molecular Pathogenesis</a>.</p></div></div><div id="hgc.References"><h2 id="_hgc_References_">References</h2><div id="hgc.Published_Guidelines__Consensus_Stat"><h3>Published Guidelines / Consensus Statements</h3><ul class="simple-list"><li class="half_rhythm"><div class="bk_ref" id="hgc.REF.fitzgerald.2010.436">Fitzgerald RC, Hardwick R, Huntsman D, Carneiro F, Guilford P, Blair V, Chung DC, Norton J, Ragunath K, Van Krieken JH, Dwerryhouse S, Caldas C., International Gastric Cancer Linkage Consortium.  Hereditary diffuse gastric cancer: updated consensus guidelines for clinical management and directions for future research. <span><span class="ref-journal">J Med Genet. </span>2010;<span class="ref-vol">47</span>:436–44.</span> [<a href="/pmc/articles/PMC2991043/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2991043</span></a>] [<a href="/pubmed/20591882" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20591882</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="hgc.REF.robson.2010.893">Robson ME, Storm CD, Weitzel J, Wollins DS, Offit K. American Society of Clinical Oncology; American Society of Clinical Oncology policy statement update: genetic and genomic testing for cancer susceptibility. <span><span class="ref-journal">J Clin Oncol. </span>2010;<span class="ref-vol">28</span>:893–901.</span> [<a href="/pubmed/20065170" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20065170</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="hgc.REF.van_der_post.2015.361">van der Post RS, Vogelaar IP, Carneiro F, Guilford P, Huntsman D, Hoogerbrugge N, Caldas C, Schreiber KE, Hardwick RH, Ausems MG, Bardram L, Benusiglio PR, Bisseling TM, Blair V, Bleiker E, Boussioutas A, Cats A, Coit D, DeGregorio L, Figueiredo J, Ford JM, Heijkoop E, Hermens R, Humar B, Kaurah P, Keller G, Lai J, Ligtenberg MJ, O'Donovan M, Oliveira C, Pinheiro H, Ragunath K, Rasenberg E, Richardson S, Roviello F, Schackert H, Seruca R, Taylor A, Ter Huurne A, Tischkowitz M, Joe ST, van Dijck B, van Grieken NC, van Hillegersberg R, van Sandick JW, Vehof R, van Krieken JH, Fitzgerald RC. Hereditary diffuse gastric cancer: updated clinical guidelines with an emphasis on germline CDH1 mutation carriers. <span><span class="ref-journal">J Med Genet. </span>2015;<span class="ref-vol">52</span>:361–74.</span> [<a href="/pmc/articles/PMC4453626/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4453626</span></a>] [<a href="/pubmed/25979631" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 25979631</span></a>]</div></li></ul></div><div id="hgc.Literature_Cited"><h3>Literature Cited</h3><ul class="simple-list"><li class="half_rhythm"><div class="bk_ref" id="hgc.REF.ajani.2010.378">Ajani JA, Barthel JS, Bekaii-Saab T, Bentrem DJ, D'Amico TA, Das P, Denlinger C, Fuchs CS, Gerdes H, Hayman JA, Hazard L, Hofstetter WL, Ilson DH, Keswani RN, Kleinberg LR, Korn M, Meredith K, Mulcahy MF, Orringer MB, Osarogiagbon RU, Posey JA, Sasson AR, Scott WJ, Shibata S, Strong VE, Washington MK, Willett C, Wood DE, Wright CD, Yang G, et al.  Gastric cancer. <span><span class="ref-journal">J Natl Compr Canc Netw. </span>2010;<span class="ref-vol">8</span>:378–409.</span> [<a href="/pubmed/20410333" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20410333</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="hgc.REF.anastasiadis.2000.1319">Anastasiadis PZ, Reynolds AB. The p120 catenin family: complex roles in adhesion, signaling and cancer. <span><span class="ref-journal">J Cell Sci. </span>2000;<span class="ref-vol">113</span>:1319–34.</span> [<a href="/pubmed/10725216" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10725216</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="hgc.REF.barber.2008.286">Barber ME, Save V, Carneiro F, Dwerryhouse S, Lao-Sirieix P, Hardwick RH, Caldas C, Fitzgerald RC. Histopathological and molecular analysis of gastrectomy specimens from hereditary diffuse gastric cancer patients has implications for endoscopic surveillance of individuals at risk. <span><span class="ref-journal">J Pathol. </span>2008;<span class="ref-vol">216</span>:286–94.</span> [<a href="/pubmed/18825658" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18825658</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="hgc.REF.becker.1994.3845">Becker KF, Atkinson MJ, Reich U, Becker I, Nekarda H, Siewert JR, Hofler H. E-cadherin gene mutations provide clues to diffuse type gastric carcinomas. <span><span class="ref-journal">Cancer Res. </span>1994;<span class="ref-vol">54</span>:3845–52.</span> [<a href="/pubmed/8033105" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 8033105</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="hgc.REF.beer.2017.1131">Beer A, Streubel B, Asari R, Dejaco C, Oberhuber G. Gastric adenocarcinoma and proximal polyposis of the stomach (GAPPS) - a rare recently described gastric polyposis syndrome - report of a case. <span><span class="ref-journal">Z Gastroenterol. </span>2017;<span class="ref-vol">55</span>:1131–4.</span> [<a href="/pubmed/29141268" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 29141268</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="hgc.REF.berx.1995.281">Berx G, Staes K, van Hengel J, Molemans F, Bussemakers MJ, van Bokhoven A, van Roy F. Cloning and characterization of the human invasion suppressor gene E-cadherin (CDH1). <span><span class="ref-journal">Genomics. </span>1995;<span class="ref-vol">26</span>:281–9.</span> [<a href="/pubmed/7601454" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 7601454</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="hgc.REF.birchmeier.1995.97">Birchmeier W. E-cadherin as a tumor (invasion) suppressor gene. <span><span class="ref-journal">Bioessays. </span>1995;<span class="ref-vol">17</span>:97–9.</span> [<a href="/pubmed/7748170" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 7748170</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="hgc.REF.blair.2006.262">Blair V, Martin I, Shaw D, Winship I, Kerr D, Arnold J, Harawira P, McLeod M, Parry S, Charlton A, Findlay M, Cox B, Humar B, More H, Guilford P. Hereditary diffuse gastric cancer: diagnosis and management. <span><span class="ref-journal">Clin Gastroenterol Hepatol. </span>2006;<span class="ref-vol">4</span>:262–75.</span> [<a href="/pubmed/16527687" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16527687</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="hgc.REF.brandberg.2008.3943">Brandberg Y, Sandelin K, Erikson S, Jurell G, Liljegren A, Lindblom A, Lind&#x000e9;n A, von Wachenfeldt A, Wickman M, Arver B. Psychological reactions, quality of life, and body image after bilateral prophylactic mastectomy in women at high risk for breast cancer: a prospective 1-year follow-up study. <span><span class="ref-journal">J Clin Oncol. </span>2008;<span class="ref-vol">26</span>:3943–9.</span> [<a href="/pubmed/18711183" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18711183</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="hgc.REF.breast_cancer_linkage_consortium.1999.1310">Breast Cancer Linkage Consortium.  Cancer risks in BRCA2 mutation carriers. <span><span class="ref-journal">J Natl Cancer Inst. </span>1999;<span class="ref-vol">91</span>:1310–6.</span> [<a href="/pubmed/10433620" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10433620</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="hgc.REF.brookswilson.2004.508">Brooks-Wilson AR, Kaurah P, Suriano G, Leach S, Senz J, Grehan N, Butterfield YS, Jeyes J, Schinas J, Bacani J, Kelsey M, Ferreira P, MacGillivray B, MacLeod P, Micek M, Ford J, Foulkes W, Australie K, Greenberg C, LaPointe M, Gilpin C, Nikkel S, Gilchrist D, Hughes R, Jackson CE, Monaghan KG, Oliveira MJ, Seruca R, Gallinger S, Caldas C, Huntsman D. Germline E-cadherin mutations in hereditary diffuse gastric cancer: assessment of 42 new families and review of genetic screening criteria. <span><span class="ref-journal">J Med Genet. </span>2004;<span class="ref-vol">41</span>:508–17.</span> [<a href="/pmc/articles/PMC1735838/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1735838</span></a>] [<a href="/pubmed/15235021" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15235021</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="hgc.REF.brose.2002.1365">Brose MS, Rebbeck TR, Calzone KA, Stopfer JE, Nathanson KL, Weber BL. Cancer risk estimates for BRCA1 mutation carriers identified in a risk evaluation program. <span><span class="ref-journal">J Natl Cancer Inst. </span>2002;<span class="ref-vol">94</span>:1365–72.</span> [<a href="/pubmed/12237282" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12237282</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="hgc.REF.bryant.2004.427">Bryant DM, Stow JL. The ins and outs of E-cadherin trafficking. <span><span class="ref-journal">Trends Cell Biol. </span>2004;<span class="ref-vol">14</span>:427–34.</span> [<a href="/pubmed/15308209" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15308209</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="hgc.REF.caldas.1999.873">Caldas C, Carneiro F, Lynch HT, Yokota J, Wiesner GL, Powell SM, Lewis FR, Huntsman DG, Pharoah PD, Jankowski JA, MacLeod P, Vogelsang H, Keller G, Park KG, Richards FM, Maher ER, Gayther SA, Oliveira C, Grehan N, Wight D, Seruca R, Roviello F, Ponder BA, Jackson CE. Familial gastric cancer: overview and guidelines for management. <span><span class="ref-journal">J Med Genet. </span>1999;<span class="ref-vol">36</span>:873–80.</span> [<a href="/pmc/articles/PMC1734270/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1734270</span></a>] [<a href="/pubmed/10593993" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10593993</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="hgc.REF.canedo.2008.1504">Canedo P, Corso G, Pereira F, Lunet N, Suriano G, Figueiredo C, Pedrazzani C, Moreira H, Barros H, Carneiro F, Seruca R, Roviello F, Machado JC. The interferon gamma receptor 1 (IFNGR1) -56C/T gene polymorphism is associated with increased risk of early gastric carcinoma. <span><span class="ref-journal">Gut. </span>2008;<span class="ref-vol">57</span>:1504–8.</span> [<a href="/pubmed/18593809" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18593809</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="hgc.REF.capelle.2010.487">Capelle LG, Van Grieken NC, Lingsma HF, Steyerberg EW, Klokman WJ, Bruno MJ, Vasen HF, Kuipers EJ. Risk and epidemiological time trends of gastric cancer in Lynch syndrome carriers in the Netherlands. <span><span class="ref-journal">Gastroenterology. </span>2010;<span class="ref-vol">138</span>:487–92.</span> [<a href="/pubmed/19900449" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19900449</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="hgc.REF.carneiro.2004.681">Carneiro F, Huntsman DG, Smyrk TC, Owen DA, Seruca R, Pharoah P, Caldas C, Sobrinho-Simoes M. Model of the early development of diffuse gastric cancer in E-cadherin mutation carriers and its implications for patient screening. <span><span class="ref-journal">J Pathol. </span>2004;<span class="ref-vol">203</span>:681–7.</span> [<a href="/pubmed/15141383" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15141383</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="hgc.REF.carney.1977.1517">Carney JA, Sheps SG, Go VL, Gordon H. The triad of gastric leiomyosarcoma, functioning extra-adrenal paraganglioma and pulmonary chondroma. <span><span class="ref-journal">N Engl J Med. </span>1977;<span class="ref-vol">296</span>:1517–8.</span> [<a href="/pubmed/865533" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 865533</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="hgc.REF.carney.2002.132">Carney JA, Stratakis CA. Familial paraganglioma and gastric stromal sarcoma: a new syndrome distinct from the Carney triad. <span><span class="ref-journal">Am J Med Genet. </span>2002;<span class="ref-vol">108</span>:132–9.</span> [<a href="/pubmed/11857563" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11857563</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="hgc.REF.chng.2009.918">Ch'ng S, Tan ST. Genetics cellular biology and tumor microenvironment of melanoma. <span><span class="ref-journal">Front Biosci (Landmark Ed). </span>2009;<span class="ref-vol">14</span>:918–28.</span> [<a href="/pubmed/19273108" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19273108</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="hgc.REF.charlton.2004.814">Charlton A, Blair V, Shaw D, Parry S, Guilford P, Martin IG. Hereditary diffuse gastric cancer: predominance of multiple foci of signet ring cell carcinoma in distal stomach and transitional zone. <span><span class="ref-journal">Gut. </span>2004;<span class="ref-vol">53</span>:814–20.</span> [<a href="/pmc/articles/PMC1774074/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1774074</span></a>] [<a href="/pubmed/15138207" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15138207</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="hgc.REF.conaccisorrell.2003.847">Conacci-Sorrell M, Simcha I, Ben-Yedidia T, Blechman J, Savagner P, Ben-Ze'ev A. Autoregulation of E-cadherin expression by cadherin-cadherin interactions: the roles of beta-catenin signaling, Slug, and MAPK. <span><span class="ref-journal">J Cell Biol. </span>2003;<span class="ref-vol">163</span>:847–57.</span> [<a href="/pmc/articles/PMC2173691/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2173691</span></a>] [<a href="/pubmed/14623871" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 14623871</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="hgc.REF.corso.2012.177">Corso G, Marrelli D, Roviello F. Familial gastric cancer and germline mutations of E-cadherin. <span><span class="ref-journal">Ann Ital Chir. </span>2012;<span class="ref-vol">83</span>:177–82.</span> [<a href="/pubmed/22595728" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22595728</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="hgc.REF.cunningham.2006.11">Cunningham D, Allum WH, Stenning SP, Thompson JN, Van de Velde CJ, Nicolson M, Scarffe JH, Lofts FJ, Falk SJ, Iveson TJ, Smith DB, Langley RE, Verma M, Weeden S, Chua YJ., MAGIC Trial Participants.  Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer. <span><span class="ref-journal">N Engl J Med. </span>2006;<span class="ref-vol">355</span>:11–20.</span> [<a href="/pubmed/16822992" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16822992</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="hgc.REF.day.1999.9656">Day ML, Zhao X, Vallorosi CJ, Putzi M, Powell CT, Lin C, Day KC. E-cadherin mediates aggregation-dependent survival of prostate and mammary epithelial cells through the retinoblastoma cell cycle control pathway. <span><span class="ref-journal">J Biol Chem. </span>1999;<span class="ref-vol">274</span>:9656–64.</span> [<a href="/pubmed/10092652" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10092652</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="hgc.REF.derrico.2009.461">D'Errico M, de Rinaldis E, Blasi MF, Viti V, Falchetti M, Calcagnile A, Sera F, Saieva C, Ottini L, Palli D, Palombo F, Giuliani A, Dogliotti E. Genome-wide expression profile of sporadic gastric cancers with microsatellite instability. <span><span class="ref-journal">Eur J Cancer. </span>2009;<span class="ref-vol">45</span>:461–9.</span> [<a href="/pubmed/19081245" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19081245</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="hgc.REF.dussaulxgarin.2001.711">Dussaulx-Garin L, Blayau M, Pagenault M, Le Berre-Heresbach N, Raoul JL, Campion JP, David V, Bretagne JF. A new mutation of E-cadherin gene in familial gastric linitis plastica cancer with extra-digestive dissemination. <span><span class="ref-journal">Eur J Gastroenterol Hepatol. </span>2001;<span class="ref-vol">13</span>:711–5.</span> [<a href="/pubmed/11434599" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11434599</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="hgc.REF.falchetti.2008.925">Falchetti M, Saieva C, Lupi R, Masala G, Rizzolo P, Zanna I, Ceccarelli K, Sera F, Mariani-Costantini R, Nesi G, Palli D, Ottini L. Gastric cancer with high-level microsatellite instability: target gene mutations, clinicopathologic features, and long-term survival. <span><span class="ref-journal">Hum Pathol. </span>2008;<span class="ref-vol">39</span>:925–32.</span> [<a href="/pubmed/18440592" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18440592</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="hgc.REF.fennerty.1999.423">Fennerty MB. Tissue staining (chromoscopy) of the gastrointestinal tract. <span><span class="ref-journal">Can J Gastroenterol. </span>1999;<span class="ref-vol">13</span>:423–9.</span> [<a href="/pubmed/10377475" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10377475</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="hgc.REF.figer.2001.478">Figer A, Irmin L, Geva R, Flex D, Sulkes J, Sulkes A, Friedman E. The rate of the 6174delT founder Jewish mutation in BRCA2 in patients with non-colonic gastrointestinal tract tumours in Israel. <span><span class="ref-journal">Br J Cancer. </span>2001;<span class="ref-vol">84</span>:478–81.</span> [<a href="/pmc/articles/PMC2363777/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2363777</span></a>] [<a href="/pubmed/11207041" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11207041</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="hgc.REF.fitzgerald.2004.775">Fitzgerald RC, Caldas C. Clinical implications of E-cadherin associated hereditary diffuse gastric cancer. <span><span class="ref-journal">Gut. </span>2004;<span class="ref-vol">53</span>:775–8.</span> [<a href="/pmc/articles/PMC1774077/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1774077</span></a>] [<a href="/pubmed/15138199" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15138199</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="hgc.REF.fitzgerald.2010.436_1">Fitzgerald RC, Hardwick R, Huntsman D, Carneiro F, Guilford P, Blair V, Chung DC, Norton J, Ragunath K, Van Krieken JH, Dwerryhouse S, Caldas C., International Gastric Cancer Linkage Consortium.  Hereditary diffuse gastric cancer: updated consensus guidelines for clinical management and directions for future research. <span><span class="ref-journal">J Med Genet. </span>2010;<span class="ref-vol">47</span>:436–44.</span> [<a href="/pmc/articles/PMC2991043/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2991043</span></a>] [<a href="/pubmed/20591882" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20591882</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="hgc.REF.frebourg.2006.138">Frebourg T, Oliveira C, Hochain P, Karam R, Manouvrier S, Graziadio C, Vekemans M, Hartmann A, Baert-Desurmont S, Alexandre C, Lejeune Dumoulin S, Marroni C, Martin C, Castedo S, Lovett M, Winston J, Machado JC, Atti&#x000e9; T, Jabs EW, Cai J, Pellerin P, Triboulet JP, Scotte M, Le Pessot F, Hedouin A, Carneiro F, Blayau M, Seruca R. Cleft lip/palate and CDH1/E-cadherin mutations in families with hereditary diffuse gastric cancer. <span><span class="ref-journal">J Med Genet. </span>2006;<span class="ref-vol">43</span>:138–42.</span> [<a href="/pmc/articles/PMC2564630/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2564630</span></a>] [<a href="/pubmed/15831593" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15831593</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="hgc.REF.friedenson.2005.60">Friedenson B. BRCA1 and BRCA2 pathways and the risk of cancers other than breast or ovarian. <span><span class="ref-journal">MedGenMed. </span>2005;<span class="ref-vol">7</span>:60.</span> [<a href="/pmc/articles/PMC1681605/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1681605</span></a>] [<a href="/pubmed/16369438" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16369438</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="hgc.REF.gayther.1998.4086">Gayther SA, Gorringe KL, Ramus SJ, Huntsman D, Roviello F, Grehan N, Machado JC, Pinto E, Seruca R, Halling K, MacLeod P, Powell SM, Jackson CE, Ponder BA, Caldas C. Identification of germ-line E-cadherin mutations in gastric cancer families of European origin. <span><span class="ref-journal">Cancer Res. </span>1998;<span class="ref-vol">58</span>:4086–9.</span> [<a href="/pubmed/9751616" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9751616</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="hgc.REF.ghaffari.2010.559">Ghaffari SR, Rafati M, Sabokbar T, Dastan J. A novel truncating mutation in the E-cadherin gene in the first Iranian family with hereditary diffuse gastric cancer. <span><span class="ref-journal">Eur J Surg Oncol. </span>2010;<span class="ref-vol">36</span>:559–62.</span> [<a href="/pubmed/20471195" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20471195</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="hgc.REF.giroldi.2000.31">Giroldi LA, Shimazui T, Schalken JA, Yamasaki H, Bringuier PP. Classical cadherins in urological cancers. <span><span class="ref-journal">Morphologie. </span>2000;<span class="ref-vol">84</span>:31–8.</span> [<a href="/pubmed/11048296" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11048296</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="hgc.REF.gloushankova.2008.742">Gloushankova NA. Changes in regulation of cell-cell adhesion during tumor transformation. <span><span class="ref-journal">Biochemistry (Mosc). </span>2008;<span class="ref-vol">73</span>:742–50.</span> [<a href="/pubmed/18707582" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18707582</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="hgc.REF.grady.2000.16">Grady WM, Willis J, Guilford PJ, Dunbier AK, Toro TT, Lynch H, Wiesner G, Ferguson K, Eng C, Park JG, Kim SJ, Markowitz S. Methylation of the CDH1 promoter as the second genetic hit in hereditary diffuse gastric cancer. <span><span class="ref-journal">Nat Genet. </span>2000;<span class="ref-vol">26</span>:16–7.</span> [<a href="/pubmed/10973239" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10973239</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="hgc.REF.guilford.1998.402">Guilford P, Hopkins J, Harraway J, McLeod M, McLeod N, Harawira P, Taite H, Scoular R, Miller A, Reeve AE. E-cadherin germline mutations in familial gastric cancer. <span><span class="ref-journal">Nature. </span>1998;<span class="ref-vol">392</span>:402–5.</span> [<a href="/pubmed/9537325" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9537325</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="hgc.REF.hansford.2015.23">Hansford S, Kaurah P, Li-Chang H, Woo M, Senz J, Pinheiro H, Schrader KA, Schaeffer DF, Shumansky K, Zogopoulos G, Santos TA, Claro I, Carvalho J, Nielsen C, Padilla S, Lum A, Talhouk A, Baker-Lange K, Richardson S, Lewis I, Lindor NM, Pennell E, MacMillan A, Fernandez B, Keller G, Lynch H, Shah SP, Guilford P, Gallinger S, Corso G, Roviello F, Caldas C, Oliveira C, Pharoah PD, Huntsman DG. Hereditary diffuse gastric cancer syndrome: CDH1 mutations and beyond. <span><span class="ref-journal">JAMA Oncol. </span>2015;<span class="ref-vol">1</span>:23–32.</span> [<a href="/pubmed/26182300" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 26182300</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="hgc.REF.hirohashi.2000.28">Hirohashi S. Molecular aspects of adhesion-epigenetic mechanisms for inactivation of the E-Cadherin-mediated cell adhesion system in cancers. <span><span class="ref-journal">Verh Dtsch Ges Pathol. </span>2000;<span class="ref-vol">84</span>:28–32.</span> [<a href="/pubmed/11217445" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11217445</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="hgc.REF.hsu.2000.1515">Hsu MY, Meier FE, Nesbit M, Hsu JY, Van Belle P, Elder DE, Herlyn M. E-cadherin expression in melanoma cells restores keratinocyte-mediated growth control and down-regulates expression of invasion-related adhesion receptors. <span><span class="ref-journal">Am J Pathol. </span>2000;<span class="ref-vol">156</span>:1515–25.</span> [<a href="/pmc/articles/PMC1876923/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1876923</span></a>] [<a href="/pubmed/10793063" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10793063</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="hgc.REF.humar.2002.518">Humar B, Toro T, Graziano F, Muller H, Dobbie Z, Kwang-Yang H, Eng C, Hampel H, Gilbert D, Winship I, Parry S, Ward R, Findlay M, Christian A, Tucker M, Tucker K, Merriman T, Guilford P. Novel germline CDH1 mutations in hereditary diffuse gastric cancer families. <span><span class="ref-journal">Hum Mutat. </span>2002;<span class="ref-vol">19</span>:518–25.</span> [<a href="/pubmed/11968084" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11968084</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="hgc.REF.humar.2007.2480">Humar B, Fukuzawa R, Blair V, Dunbier A, More H, Charlton A, Yang HK, Kim WH, Reeve AE, Martin I, Guilford P. Destabilized adhesion in the gastric proliferative zone and c-Src kinase activation mark the development of early diffuse gastric cancer. <span><span class="ref-journal">Cancer Res. </span>2007;<span class="ref-vol">67</span>:2480–9.</span> [<a href="/pubmed/17363565" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17363565</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="hgc.REF.h_neburg.2016.e1305">H&#x000fc;neburg R, Marwitz T, van Heteren P, Weism&#x000fc;ller TJ, Trebicka J, Adam R, Aretz S, Perez Bouza A, Pantelis D, Kalff JC, Nattermann J, Strassburg CP. Chromoendoscopy in combination with random biopsies does not improve detection of gastric cancer foci in CDH1 mutation positive patients. <span><span class="ref-journal">Endosc Int Open. </span>2016;<span class="ref-vol">4</span>:E1305–10.</span> [<a href="/pmc/articles/PMC5161122/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC5161122</span></a>] [<a href="/pubmed/27995193" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 27995193</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="hgc.REF.jagelman.1988.1149">Jagelman DG, DeCosse JJ, Bussey HJ. Upper gastrointestinal cancer in familial adenomatous polyposis. <span><span class="ref-journal">Lancet. </span>1988;<span class="ref-vol">1</span>:1149–51.</span> [<a href="/pubmed/2896968" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 2896968</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="hgc.REF.jakubowska.2002.888">Jakubowska A, Nej K, Huzarski T, Scott RJ, Lubinski J. BRCA2 gene mutations in families with aggregations of breast and stomach cancers. <span><span class="ref-journal">Br J Cancer. </span>2002;<span class="ref-vol">87</span>:888–91.</span> [<a href="/pmc/articles/PMC2376177/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2376177</span></a>] [<a href="/pubmed/12373604" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12373604</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="hgc.REF.jonsson.2002.838">Jonsson BA, Bergh A, Stattin P, Emmanuelsson M, Gr&#x000f6;nberg H. Germline mutations in E-cadherin do not explain association of hereditary prostate cancer, gastric cancer and breast cancer. <span><span class="ref-journal">Int J Cancer. </span>2002;<span class="ref-vol">98</span>:838–43.</span> [<a href="/pubmed/11948460" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11948460</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="hgc.REF.jou.1995.5067">Jou TS, Stewart DB, Stappert J, Nelson WJ, Marrs JA. Genetic and biochemical dissection of protein linkages in the cadherin- catenin complex. <span><span class="ref-journal">Proc Natl Acad Sci U S A. </span>1995;<span class="ref-vol">92</span>:5067–71.</span> [<a href="/pmc/articles/PMC41849/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC41849</span></a>] [<a href="/pubmed/7761449" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 7761449</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="hgc.REF.kallakury.2001.2786">Kallakury BV, Sheehan CE, Winn-Deen E, Oliver J, Fisher HA, Kaufman RP Jr, Ross JS. Decreased expression of catenins (alpha and beta), p120 CTN, and E-cadherin cell adhesion proteins and E-cadherin gene promoter methylation in prostatic adenocarcinomas. <span><span class="ref-journal">Cancer. </span>2001;<span class="ref-vol">92</span>:2786–95.</span> [<a href="/pubmed/11753952" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11753952</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="hgc.REF.karayiannakis.2001.31">Karayiannakis AJ, Nakopoulou L, Gakiopoulou H, Keramopoulos A, Davaris PS, Pignatelli M. Expression patterns of beta-catenin in in situ and invasive breast cancer. <span><span class="ref-journal">Eur J Surg Oncol. </span>2001;<span class="ref-vol">27</span>:31–6.</span> [<a href="/pubmed/11237489" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11237489</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="hgc.REF.kaurah.2010.331">Kaurah P, Fitzgerald R, Dwerryhouse S, Huntsman DG. Pregnancy after prophylactic total gastrectomy. <span><span class="ref-journal">Fam Cancer. </span>2010;<span class="ref-vol">9</span>:331–4.</span> [<a href="/pubmed/20063069" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20063069</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="hgc.REF.kaurah.2007.2360">Kaurah P, MacMillan A, Boyd N, Senz J, De Luca A, Chun N, Suriano G, Zaor S, Van Manen L, Gilpin C, Nikkel S, Connolly-Wilson M, Weissman S, Rubinstein WS, Sebold C, Greenstein R, Stroop J, Yim D, Panzini B, McKinnon W, Greenblatt M, Wirtzfeld D, Fontaine D, Coit D, Yoon S, Chung D, Lauwers G, Pizzuti A, Vaccaro C, Redal MA, Oliveira C, Tischkowitz M, Olschwang S, Gallinger S, Lynch H, Green J, Ford J, Pharoah P, Fernandez B, Huntsman D. Founder and recurrent CDH1 mutations in families with hereditary diffuse gastric cancer. <span><span class="ref-journal">JAMA. </span>2007;<span class="ref-vol">297</span>:2360–72.</span> [<a href="/pubmed/17545690" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17545690</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="hgc.REF.keller.2002.229">Keller G. Hereditary aspects of gastric cancer. <span><span class="ref-journal">Pathologica. </span>2002;<span class="ref-vol">94</span>:229–33.</span> [<a href="/pubmed/12417969" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12417969</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="hgc.REF.keller.2004.e89">Keller G, Vogelsang H, Becker I, Plaschke S, Ott K, Suriano G, Mateus AR, Seruca R, Biedermann K, Huntsman D, D&#x000f6;ring C, Holinski-Feder E, Neutzling A, Siewert JR, H&#x000f6;fler H. Germline mutations of the E-cadherin(CDH1) and TP53 genes, rather than of RUNX3 and HPP1, contribute to genetic predisposition in German gastric cancer patients. <span><span class="ref-journal">J Med Genet. </span>2004;<span class="ref-vol">41</span>:e89.</span> [<a href="/pmc/articles/PMC1735803/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1735803</span></a>] [<a href="/pubmed/15173255" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15173255</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="hgc.REF.knudson.1971.820">Knudson AG Jr. Mutation and cancer: statistical study of retinoblastoma. <span><span class="ref-journal">Proc Natl Acad Sci U S A. </span>1971;<span class="ref-vol">68</span>:820–3.</span> [<a href="/pmc/articles/PMC389051/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC389051</span></a>] [<a href="/pubmed/5279523" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 5279523</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="hgc.REF.kodish.1999.390">Kodish ED. Testing children for cancer genes: the rule of earliest onset. <span><span class="ref-journal">J Pediatr. </span>1999;<span class="ref-vol">135</span>:390–5.</span> [<a href="/pubmed/10484811" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10484811</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="hgc.REF.kuner.2009.32">Kuner R, Muley T, Meister M, Ruschhaupt M, Buness A, Xu EC, Schnabel P, Warth A, Poustka A, S&#x000fc;ltmann H, Hoffmann H. Global gene expression analysis reveals specific patterns of cell junctions in non-small cell lung cancer subtypes. <span><span class="ref-journal">Lung Cancer. </span>2009;<span class="ref-vol">63</span>:32–8.</span> [<a href="/pubmed/18486272" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18486272</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="hgc.REF.la_vecchia.1992.50">La Vecchia C, Negri E, Franceschi S, Gentile A. Family history and the risk of stomach and colorectal cancer. <span><span class="ref-journal">Cancer. </span>1992;<span class="ref-vol">70</span>:50–5.</span> [<a href="/pubmed/1606546" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 1606546</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="hgc.REF.lewis.2001.612">Lewis FR, Mellinger JD, Hayashi A, Lorelli D, Monaghan KG, Carneiro F, Huntsman DG, Jackson CE, Caldas C. Prophylactic total gastrectomy for familial gastric cancer. <span><span class="ref-journal">Surgery. </span>2001;<span class="ref-vol">130</span>:612–7.</span> [<a href="/pubmed/11602891" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11602891</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="hgc.REF.li.2016.830">Li J, Woods SL, Healey S, Beesley J, Chen X, Lee JS, Sivakumaran H, Wayte N, Nones K, Waterfall JJ, Pearson J, Patch AM, Senz J, Ferreira MA, Kaurah P, Mackenzie R, Heravi-Moussavi A, Hansford S, Lannagan TRM, Spurdle AB, Simpson PT, da Silva L, Lakhani SR, Clouston AD, Bettington M, Grimpen F, Busuttil RA, Di Costanzo N, Boussioutas A, Jeanjean M, Chong G, Fabre A, Olschwang S, Faulkner GJ, Bellos E, Coin L, Rioux K, Bathe OF, Wen X, Martin HC, Neklason DW, Davis SR, Walker RL, Calzone KA, Avital I, Heller T, Koh C, Pineda M, Rudloff U, Quezado M, Pichurin PN, Hulick PJ, Weissman SM, Newlin A, Rubinstein WS, Sampson JE, Hamman K, Goldgar D, Poplawski N, Phillips K, Schofield L, Armstrong J, Kiraly-Borri C, Suthers GK, Huntsman DG, Foulkes WD, Carneiro F, Lindor NM, Edwards SL, French JD, Waddell N, Meltzer PS, Worthley DL, Schrader KA, Chenevix-Trench G. Point mutations in exon 1B of APC reveal gastric adenocarcinoma and proximal polyposis of the stomach as a familial adenomatous polyposis variant. <span><span class="ref-journal">Am J Hum Genet. </span>2016;<span class="ref-vol">98</span>:830–42.</span> [<a href="/pmc/articles/PMC4863475/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4863475</span></a>] [<a href="/pubmed/27087319" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 27087319</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="hgc.REF.lynch.2005.114">Lynch HT, Grady W, Suriano G, Huntsman D. Gastric cancer: new genetic developments. <span><span class="ref-journal">J Surg Oncol. </span>2005;<span class="ref-vol">90</span>:114–33.</span> [<a href="/pubmed/15895459" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15895459</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="hgc.REF.macdonald.2000">Macdonald J, Smalley S, Benedetti J, et al. Postoperative combined radiation and chemotherapy improves disease-free survival (DFS) and overall survival (OS) in resected adenocarcinoma of the stomach and GE junction. Results of intergroup study INT-0116 (SWOG 9008). Abstract #1. New Orleans, LA: American Society of Clinical Oncology Annual Meeting. 2000.</div></li><li class="half_rhythm"><div class="bk_ref" id="hgc.REF.machado.2001.1525">Machado JC, Oliveira C, Carvalho R, Soares P, Berx G, Caldas C, Seruca R, Carneiro F, Sobrinho-Simoes M. E-cadherin gene (CDH1) promoter methylation as the second hit in sporadic diffuse gastric carcinoma. <span><span class="ref-journal">Oncogene. </span>2001;<span class="ref-vol">20</span>:1525–8.</span> [<a href="/pubmed/11313896" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11313896</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="hgc.REF.malkin.2011.475">Malkin D. Li-fraumeni syndrome. <span><span class="ref-journal">Genes Cancer. </span>2011;<span class="ref-vol">2</span>:475–84.</span> [<a href="/pmc/articles/PMC3135649/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3135649</span></a>] [<a href="/pubmed/21779515" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21779515</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="hgc.REF.masciari.2007.726">Masciari S, Larsson N, Senz J, Boyd N, Kaurah P, Kandel MJ, Harris LN, Pinheiro HC, Troussard A, Miron P, Tung N, Oliveira C, Collins L, Schnitt S, Garber JE, Huntsman D. Germline E-cadherin mutations in familial lobular breast cancer. <span><span class="ref-journal">J Med Genet. </span>2007;<span class="ref-vol">44</span>:726–31.</span> [<a href="/pmc/articles/PMC2752184/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2752184</span></a>] [<a href="/pubmed/17660459" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17660459</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="hgc.REF.mayrbaeurl.2010.306">Mayrbaeurl B, Keller G, Schauer W, Burgstaller S, Czompo M, Hoebling W, Knoflach P, Duba HC, Hoefler H, Thaler J. Germline mutation of the E-cadherin gene in three sibling cases with advanced gastric cancer: clinical consequences for the other family members. <span><span class="ref-journal">Eur J Gastroenterol Hepatol. </span>2010;<span class="ref-vol">22</span>:306–10.</span> [<a href="/pubmed/19474748" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19474748</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="hgc.REF.mccoll.2006.687">McColl KE. Cancer of the gastric cardia. <span><span class="ref-journal">Best Pract Res Clin Gastroenterol. </span>2006;<span class="ref-vol">20</span>:687–96.</span> [<a href="/pubmed/16997153" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16997153</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="hgc.REF.mi.2018.408">Mi EZ, Mi EZ, di Pietro M, O'Donovan M, Hardwick RH, Richardson S, Ziauddeen H, Fletcher PC, Caldas C, Tischkowitz M, Ragunath K, Fitzgerald RC. Comparative study of endoscopic surveillance in hereditary diffuse gastric cancer according to CDH1 mutation status. <span><span class="ref-journal">Gastrointest Endosc. </span>2018;<span class="ref-vol">87</span>:408–18.</span> [<a href="/pmc/articles/PMC5780354/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC5780354</span></a>] [<a href="/pubmed/28688938" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 28688938</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="hgc.REF.more.2007.203">More H, Humar B, Weber W, Ward R, Christian A, Lintott C, Graziano F, Ruzzo AM, Acosta E, Boman B, Harlan M, Ferreira P, Seruca R, Suriano G, Guilford P. Identification of seven novel germline mutations in the human E-cadherin (CDH1) gene. <span><span class="ref-journal">Hum Mutat. </span>2007;<span class="ref-vol">28</span>:203.</span> [<a href="/pubmed/17221870" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17221870</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="hgc.REF.muir.2016.1950">Muir J, Aronson M, Esplen MJ, Pollett A, Swallow CJ. Prophylactic total gastrectomy: a prospective cohort study of long-term impact on quality of life. <span><span class="ref-journal">J Gastrointest Surg. </span>2016;<span class="ref-vol">20</span>:1950–8.</span> [<a href="/pubmed/27752808" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 27752808</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="hgc.REF.nagar.1996.360">Nagar B, Overduin M, Ikura M, Rini JM. Structural basis of calcium-induced E-cadherin rigidification and dimerization. <span><span class="ref-journal">Nature. </span>1996;<span class="ref-vol">380</span>:360–4.</span> [<a href="/pubmed/8598933" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 8598933</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="hgc.REF.nelson.2004.1483">Nelson WJ, Nusse R. Convergence of Wnt, beta-catenin, and cadherin pathways. <span><span class="ref-journal">Science. </span>2004;<span class="ref-vol">303</span>:1483–7.</span> [<a href="/pmc/articles/PMC3372896/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3372896</span></a>] [<a href="/pubmed/15001769" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15001769</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="hgc.REF.norton.2007.873">Norton JA, Ham CM, Van Dam J, Jeffrey RB, Longacre TA, Huntsman DG, Chun N, Kurian AW, Ford JM. CDH1 truncating mutations in the E-cadherin gene: an indication for total gastrectomy to treat hereditary diffuse gastric cancer. <span><span class="ref-journal">Ann Surg. </span>2007;<span class="ref-vol">245</span>:873–9.</span> [<a href="/pmc/articles/PMC1876967/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1876967</span></a>] [<a href="/pubmed/17522512" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17522512</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="hgc.REF.oda.1994.1858">Oda T, Kanai Y, Oyama T, Yoshiura K, Shimoyama Y, Birchmeier W, Sugimura T, Hirohashi S. E-cadherin gene mutations in human gastric carcinoma cell lines. <span><span class="ref-journal">Proc Natl Acad Sci U S A. </span>1994;<span class="ref-vol">91</span>:1858–62.</span> [<a href="/pmc/articles/PMC43263/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC43263</span></a>] [<a href="/pubmed/8127895" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 8127895</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="hgc.REF.oliveira.2002.510">Oliveira C, Bordin MC, Grehan N, Huntsman D, Suriano G, Machado JC, Kiviluoto T, Aaltonen L, Jackson CE, Seruca R, Caldas C. Screening E-cadherin in gastric cancer families reveals germline mutations only in hereditary diffuse gastric cancer kindred. <span><span class="ref-journal">Hum Mutat. </span>2002;<span class="ref-vol">19</span>:510–7.</span> [<a href="/pubmed/11968083" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11968083</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="hgc.REF.oliveira.2004.1897">Oliveira C, Ferreira P, Nabais S, Campos L, Ferreira A, Cirnes L, Alves CC, Veiga I, Fragoso M, Regateiro F, Dias LM, Moreira H, Suriano G, Machado JC, Lopes C, Castedo S, Carneiro F, Seruca R. E-Cadherin (CDH1) and p53 rather than SMAD4 and Caspase-10 germline mutations contribute to genetic predisposition in Portuguese gastric cancer patients. <span><span class="ref-journal">Eur J Cancer. </span>2004;<span class="ref-vol">40</span>:1897–903.</span> [<a href="/pubmed/15288293" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15288293</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="hgc.REF.oliveira.2009.1545">Oliveira C, Senz J, Kaurah P, Pinheiro H, Sanges R, Haegert A, Corso G, Schouten J, Fitzgerald R, Vogelsang H, Keller G, Dwerryhouse S, Grimmer D, Chin SF, Yang HK, Jackson CE, Seruca R, Roviello F, Stupka E, Caldas C, Huntsman D. Germline CDH1 deletions in hereditary diffuse gastric cancer families. <span><span class="ref-journal">Hum Mol Genet. </span>2009;<span class="ref-vol">18</span>:1545–55.</span> [<a href="/pmc/articles/PMC2667284/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2667284</span></a>] [<a href="/pubmed/19168852" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19168852</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="hgc.REF.oliveira.2003.201">Oliveira C, Seruca R, Caldas C. Genetic screening for hereditary diffuse gastric cancer. <span><span class="ref-journal">Expert Rev Mol Diagn. </span>2003;<span class="ref-vol">3</span>:201–15.</span> [<a href="/pubmed/12647996" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12647996</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="hgc.REF.oliveira.2006.21">Oliveira C, Seruca R, Carneiro F. Genetics, pathology, and clinics of familial gastric cancer. <span><span class="ref-journal">Int J Surg Pathol. </span>2006;<span class="ref-vol">14</span>:21–33.</span> [<a href="/pubmed/16501831" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16501831</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="hgc.REF.olivier.2003.6643">Olivier M, Goldgar DE, Sodha N, Ohgaki H, Kleihues P, Hainaut P, Eeles RA. Li-Fraumeni and related syndromes: correlation between tumor type, family structure, and TP53 genotype. <span><span class="ref-journal">Cancer Res. </span>2003;<span class="ref-vol">63</span>:6643–50.</span> [<a href="/pubmed/14583457" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 14583457</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="hgc.REF.pasini.2008.79">Pasini B, McWhinney SR, Bei T, Matyakhina L, Stergiopoulos S, Muchow M, Boikos SA, Ferrando B, Pacak K, Assie G, Baudin E, Chompret A, Ellison JW, Briere JJ, Rustin P, Gimenez-Roqueplo AP, Eng C, Carney JA, Stratakis CA. Clinical and molecular genetics of patients with the Carney-Stratakis syndrome and germline mutations of the genes coding for the succinate dehydrogenase subunits SDHB, SDHC, and SDHD. <span><span class="ref-journal">Eur J Hum Genet. </span>2008;<span class="ref-vol">16</span>:79–88.</span> [<a href="/pubmed/17667967" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17667967</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="hgc.REF.perl.1998.190">Perl AK, Wilgenbus P, Dahl U, Semb H, Christofori G. A causal role for E-cadherin in the transition from adenoma to carcinoma. <span><span class="ref-journal">Nature. </span>1998;<span class="ref-vol">392</span>:190–3.</span> [<a href="/pubmed/9515965" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9515965</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="hgc.REF.pfau.2002.21">Pfau PR, Chak A. Endoscopic ultrasonography. <span><span class="ref-journal">Endoscopy. </span>2002;<span class="ref-vol">34</span>:21–8.</span> [<a href="/pubmed/11778127" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11778127</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="hgc.REF.pharoah.2001.1348">Pharoah PD, Guilford P, Caldas C. Incidence of gastric cancer and breast cancer in CDH1 (E-cadherin) mutation carriers from hereditary diffuse gastric cancer families. <span><span class="ref-journal">Gastroenterology. </span>2001;<span class="ref-vol">121</span>:1348–53.</span> [<a href="/pubmed/11729114" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11729114</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="hgc.REF.repak.2016.718">Repak R, Kohoutova D, Podhola M, Rejchrt S, Minarik M, Benesova L, Lesko M, Bures J. The first European family with gastric adenocarcinoma and proximal polyposis of the stomach: case report and review of the literature. <span><span class="ref-journal">Gastrointest Endosc. </span>2016;<span class="ref-vol">84</span>:718–25.</span> [<a href="/pubmed/27343414" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 27343414</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="hgc.REF.richards.1999.607">Richards FM, McKee SA, Rajpar MH, Cole TR, Evans DG, Jankowski JA, McKeown C, Sanders DS, Maher ER. Germline E-cadherin gene (CDH1) mutations predispose to familial gastric cancer and colorectal cancer. <span><span class="ref-journal">Hum Mol Genet. </span>1999;<span class="ref-vol">8</span>:607–10.</span> [<a href="/pubmed/10072428" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10072428</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="hgc.REF.risch.2001.700">Risch HA, McLaughlin JR, Cole DE, Rosen B, Bradley L, Kwan E, Jack E, Vesprini DJ, Kuperstein G, Abrahamson JL, Fan I, Wong B, Narod SA. Prevalence and penetrance of germline BRCA1 and BRCA2 mutations in a population series of 649 women with ovarian cancer. <span><span class="ref-journal">Am J Hum Genet. </span>2001;<span class="ref-vol">68</span>:700–10.</span> [<a href="/pmc/articles/PMC1274482/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1274482</span></a>] [<a href="/pubmed/11179017" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11179017</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="hgc.REF.rodriguezsanjuan.2006.1110">Rodriguez-Sanjuan JC, Fontalba A, Mayorga M, Bordin MC, Hyland SJ, Trugeda S, Garcia RA, Gomez-Fleitas M, Fernandez F, Caldas C, Fernandez-Luna JL. A novel mutation in the E-cadherin gene in the first family with hereditary diffuse gastric cancer reported in Spain. <span><span class="ref-journal">Eur J Surg Oncol. </span>2006;<span class="ref-vol">32</span>:1110–3.</span> [<a href="/pubmed/16870389" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16870389</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="hgc.REF.roviello.2007.448">Roviello F, Corso G, Pedrazzani C, Marrelli D, De Falco G, Berardi A, Garosi L, Suriano G, Vindigni C, De Stefano A, Leoncini L, Seruca R, Pinto E. Hereditary diffuse gastric cancer and E-cadherin: description of the first germline mutation in an Italian family. <span><span class="ref-journal">Eur J Surg Oncol. </span>2007;<span class="ref-vol">33</span>:448–51.</span> [<a href="/pubmed/17126523" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17126523</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="hgc.REF.sahasrabudhe.2017.983">Sahasrabudhe R, Lott P, Bohorquez M, Toal T, Estrada AP, Suarez JJ, Brea-Fern&#x000e1;ndez A, Cameselle-Teijeiro J, Pinto C, Ramos I, Mantilla A, Prieto R, Corvalan A, Norero E, Alvarez C, Tapia T, Carvallo P, Gonzalez LM, Cock-Rada A, Solano A, Neffa F, Della Valle A, Yau C, Soares G, Borowsky A, Hu N, He LJ, Han XY, Taylor PR, Goldstein AM, Torres J, Echeverry M, Ruiz-Ponte C, Teixeira MR, Carvajal-Carmona LG, et al.  Germline mutations in PALB2, BRCA1, and RAD51C, which regulate DNA recombination repair, in patients with gastric cancer. <span><span class="ref-journal">Gastroenterology. </span>2017;<span class="ref-vol">152</span>:983–6.e6.</span> [<a href="/pmc/articles/PMC5367981/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC5367981</span></a>] [<a href="/pubmed/28024868" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 28024868</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="hgc.REF.sakuramoto.2007.1810">Sakuramoto S, Sasako M, Yamaguchi T, Kinoshita T, Fujii M, Nashimoto A, Furukawa H, Nakajima T, Ohashi Y, Imamura H, Higashino M, Yamamura Y, Kurita A, Arai K, et al.  Adjuvant chemotherapy for gastric cancer with S-1, an oral fluoropyrimidine. <span><span class="ref-journal">N Engl J Med. </span>2007;<span class="ref-vol">357</span>:1810–20.</span> [<a href="/pubmed/17978289" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17978289</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="hgc.REF.schrader.2011.64">Schrader KA, Masciari S, Boyd N, Salamanca C, Senz J, Saunders DN, Yorida E, Maines-Bandiera S, Kaurah P, Tung N, Robson ME, Ryan PD, Olopade OI, Domchek SM, Ford J, Isaacs C, Brown P, Balmana J, Razzak AR, Miron P, Coffey K, Terry MB, John EM, Andrulis IL, Knight JA, O'Malley FP, Daly M, Bender P, Moore R, Southey MC, Hopper JL, Garber JE, Huntsman DG, et al.  Germline mutations in CDH1 are infrequent in women with early-onset or familial lobular breast cancers. <span><span class="ref-journal">J Med Genet. </span>2011;<span class="ref-vol">48</span>:64–8.</span> [<a href="/pmc/articles/PMC3003879/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3003879</span></a>] [<a href="/pubmed/20921021" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20921021</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="hgc.REF.shah.2012.283">Shah MA, Salo-Mullen E, Stadler Z, Ruggeri JM, Mirander M, Pristyazhnyuk Y, Zhang L. De novo CDH1 mutation in a family presenting with early-onset diffuse gastric cancer. <span><span class="ref-journal">Clin Genet. </span>2012;<span class="ref-vol">82</span>:283–7.</span> [<a href="/pubmed/21696387" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21696387</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="hgc.REF.shaw.2005.461">Shaw D, Blair V, Framp A, Harawira P, McLeod M, Guilford P, Parry S, Charlton A, Martin I. Chromoendoscopic surveillance in hereditary diffuse gastric cancer: an alternative to prophylactic gastrectomy? <span><span class="ref-journal">Gut. </span>2005;<span class="ref-vol">54</span>:461–8.</span> [<a href="/pmc/articles/PMC1774455/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1774455</span></a>] [<a href="/pubmed/15753528" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15753528</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="hgc.REF.shinmura.1999.1127">Shinmura K, Kohno T, Takahashi M, Sasaki A, Ochiai A, Guilford P, Hunter A, Reeve AE, Sugimura H, Yamaguchi N, Yokota J. Familial gastric cancer: clinicopathological characteristics, RER phenotype and germline p53 and E-cadherin mutations. <span><span class="ref-journal">Carcinogenesis. </span>1999;<span class="ref-vol">20</span>:1127–31.</span> [<a href="/pubmed/10357799" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10357799</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="hgc.REF.slavin.2017.111">Slavin T, Neuhausen SL, Rybak C, Solomon I, Nehoray B, Blazer K, Niell-Swiller M, Adamson AW, Yuan YC, Yang K, Sand S, Castillo D, Herzog J, Wu X, Tao S, Chavez T, Woo Y, Chao J, Mora P, Horcasitas D, Weitzel J. Genetic gastric cancer susceptibility in the International Clinical Cancer Genomics Community Research Network. <span><span class="ref-journal">Cancer Genet. </span>2017;<span class="ref-vol">216-217</span>:111–9.</span> [<a href="/pmc/articles/PMC5659836/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC5659836</span></a>] [<a href="/pubmed/29025585" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 29025585</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="hgc.REF.stemmler.2005.965">Stemmler MP, Hecht A, Kemler R. E-cadherin intron 2 contains cis-regulatory elements essential for gene expression. <span><span class="ref-journal">Development. </span>2005;<span class="ref-vol">132</span>:965–76.</span> [<a href="/pubmed/15673570" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15673570</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="hgc.REF.stepp.1998.379">Stepp H, Sroka R, Baumgartner R. Fluorescence endoscopy of gastrointestinal diseases: basic principles, techniques, and clinical experience. <span><span class="ref-journal">Endoscopy. </span>1998;<span class="ref-vol">30</span>:379–86.</span> [<a href="/pubmed/9689513" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9689513</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="hgc.REF.stiekema.2013.686">Stiekema J, Cats A, Kuijpers A, van Coevorden F, Boot H, Jansen EP, Verheij M, Balague Ponz O, Hauptmann M, van Sandick JW. Surgical treatment results of intestinal and diffuse type gastric cancer. Implications for a differentiated therapeutic approach? <span><span class="ref-journal">Eur J Surg Oncol. </span>2013;<span class="ref-vol">39</span>:686–93.</span> [<a href="/pubmed/23498364" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23498364</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="hgc.REF.suerbaum.2002.1175">Suerbaum S, Michetti P. Helicobacter pylori infection. <span><span class="ref-journal">N Engl J Med. </span>2002;<span class="ref-vol">347</span>:1175–86.</span> [<a href="/pubmed/12374879" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12374879</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="hgc.REF.suriano.2003.575">Suriano G, Oliveira C, Ferreira P, Machado JC, Bordin MC, De Wever O, Bruyneel EA, Moguilevsky N, Grehan N, Porter TR, Richards FM, Hruban RH, Roviello F, Huntsman D, Mareel M, Carneiro F, Caldas C, Seruca R. Identification of CDH1 germline missense mutations associated with functional inactivation of the E-cadherin protein in young gastric cancer probands. <span><span class="ref-journal">Hum Mol Genet. </span>2003;<span class="ref-vol">12</span>:575–82.</span> [<a href="/pubmed/12588804" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12588804</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="hgc.REF.suriano.2005.5401">Suriano G, Yew S, Ferreira P, Senz J, Kaurah P, Ford JM, Longacre TA, Norton JA, Chun N, Young S, Oliveira MJ, Macgillivray B, Rao A, Sears D, Jackson CE, Boyd J, Yee C, Deters C, Pai GS, Hammond LS, McGivern BJ, Medgyesy D, Sartz D, Arun B, Oelschlager BK, Upton MP, Neufeld-Kaiser W, Silva OE, Donenberg TR, Kooby DA, Sharma S, Jonsson BA, Gronberg H, Gallinger S, Seruca R, Lynch H, Huntsman DG. Characterization of a recurrent germ line mutation of the E-cadherin gene: implications for genetic testing and clinical management. <span><span class="ref-journal">Clin Cancer Res. </span>2005;<span class="ref-vol">11</span>:5401–9.</span> [<a href="/pubmed/16061854" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16061854</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="hgc.REF.takeichi.1991.1451">Takeichi M. Cadherin cell adhesion receptors as a morphogenetic regulator. <span><span class="ref-journal">Science. </span>1991;<span class="ref-vol">251</span>:1451–5.</span> [<a href="/pubmed/2006419" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 2006419</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="hgc.REF.tamura.2000.569">Tamura G, Yin J, Wang S, Fleisher AS, Zou T, Abraham JM, Kong D, Smolinski KN, Wilson KT, James SP, Silverberg SG, Nishizuka S, Terashima M, Motoyama T, Meltzer SJ. E-Cadherin gene promoter hypermethylation in primary human gastric carcinomas. <span><span class="ref-journal">J Natl Cancer Inst. </span>2000;<span class="ref-vol">92</span>:569–73.</span> [<a href="/pubmed/10749913" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10749913</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="hgc.REF.tsanou.2008.3815">Tsanou E, Peschos D, Batistatou A, Charalabopoulos A, Charalabopoulos K. The E-cadherin adhesion molecule and colorectal cancer. A global literature approach. <span><span class="ref-journal">Anticancer Res. </span>2008;<span class="ref-vol">28</span>:3815–26.</span> [<a href="/pubmed/19189669" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19189669</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="hgc.REF.uemura.2001.784">Uemura N, Okamoto S, Yamamoto S, Matsumura N, Yamaguchi S, Yamakido M, Taniyama K, Sasaki N, Schlemper RJ. Helicobacter pylori infection and the development of gastric cancer. <span><span class="ref-journal">N Engl J Med. </span>2001;<span class="ref-vol">345</span>:784–9.</span> [<a href="/pubmed/11556297" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11556297</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="hgc.REF.van_der_post.2015.361_1">van der Post RS, Vogelaar IP, Carneiro F, Guilford P, Huntsman D, Hoogerbrugge N, Caldas C, Schreiber KE, Hardwick RH, Ausems MG, Bardram L, Benusiglio PR, Bisseling TM, Blair V, Bleiker E, Boussioutas A, Cats A, Coit D, DeGregorio L, Figueiredo J, Ford JM, Heijkoop E, Hermens R, Humar B, Kaurah P, Keller G, Lai J, Ligtenberg MJ, O'Donovan M, Oliveira C, Pinheiro H, Ragunath K, Rasenberg E, Richardson S, Roviello F, Schackert H, Seruca R, Taylor A, Ter Huurne A, Tischkowitz M, Joe ST, van Dijck B, van Grieken NC, van Hillegersberg R, van Sandick JW, Vehof R, van Krieken JH, Fitzgerald RC. Hereditary diffuse gastric cancer: updated clinical guidelines with an emphasis on germline CDH1 mutation carriers. <span><span class="ref-journal">J Med Genet. </span>2015;<span class="ref-vol">52</span>:361–74.</span> [<a href="/pmc/articles/PMC4453626/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4453626</span></a>] [<a href="/pubmed/25979631" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 25979631</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="hgc.REF.van_domselaar.2007.158">Van Domselaar F, Correa D, Vaccaro C, Redal M, Van Domselaar R, Huntsman D, Kaurah P, Senz J, Lynch H. Hereditary diffuse gastric cancer (HDGC): presentation of a family with a new mutation of the CDH1 gene. <span><span class="ref-journal">Acta Gastroenterol Latinoam. </span>2007;<span class="ref-vol">37</span>:158–63.</span> [<a href="/pubmed/17955726" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17955726</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="hgc.REF.van_kouwen.2004.85">van Kouwen MC, Oyen WJ, Nagengast FM, Jansen JB, Drenth JP. FDG-PET scanning in the diagnosis of gastrointestinal cancers. <span><span class="ref-journal">Scand J Gastroenterol Suppl. </span>2004;(241):85–92.</span> [<a href="/pubmed/15696855" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15696855</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="hgc.REF.wanebo.1993.583">Wanebo HJ, Kennedy BJ, Chmiel J, Steele G Jr, Winchester D, Osteen R. Cancer of the stomach. A patient care study by the American College of Surgeons. <span><span class="ref-journal">Ann Surg. </span>1993;<span class="ref-vol">218</span>:583–92.</span> [<a href="/pmc/articles/PMC1243028/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1243028</span></a>] [<a href="/pubmed/8239772" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 8239772</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="hgc.REF.weis.2006.35593">Weis WI, Nelson WJ. Re-solving the cadherin-catenin-actin conundrum. <span><span class="ref-journal">J Biol Chem. </span>2006;<span class="ref-vol">281</span>:35593–7.</span> [<a href="/pmc/articles/PMC3368706/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3368706</span></a>] [<a href="/pubmed/17005550" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17005550</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="hgc.REF.wijnhoven.2000.992">Wijnhoven BP, Dinjens WN, Pignatelli M. E-cadherin-catenin cell-cell adhesion complex and human cancer. <span><span class="ref-journal">Br J Surg. </span>2000;<span class="ref-vol">87</span>:992–1005.</span> [<a href="/pubmed/10931041" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10931041</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="hgc.REF.worster.2014.87">Worster E, Liu X, Richardson S, Hardwick RH, Dwerryhouse S, Caldas C, Fitzgerald RC. The impact of prophylactic total gastrectomy on health-related quality of life: a prospective cohort study. <span><span class="ref-journal">Ann Surg. </span>2014;<span class="ref-vol">260</span>:87–93.</span> [<a href="/pubmed/24424140" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 24424140</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="hgc.REF.worthley.2012.774">Worthley DL, Phillips KD, Wayte N, Schrader KA, Healey S, Kaurah P, Shulkes A, Grimpen F, Clouston A, Moore D, Cullen D, Ormonde D, Mounkley D, Wen X, Lindor N, Carneiro F, Huntsman DG, Chenevix-Trench G, Suthers GK. Gastric adenocarcinoma and proximal polyposis of the stomach (GAPPS): a new autosomal dominant syndrome. <span><span class="ref-journal">Gut. </span>2012;<span class="ref-vol">61</span>:774–9.</span> [<a href="/pubmed/21813476" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21813476</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="hgc.REF.yamada.2014.750">Yamada M, Fukagawa T, Nakajima T, Asada K, Sekine S, Yamashita S, Okochi-Takada E, Taniguchi H, Kushima R, Oda I, Saito Y, Ushijima T, Katai H. Hereditary diffuse gastric cancer in a Japanese family with a large deletion involving CDH1. <span><span class="ref-journal">Gastric Cancer. </span>2014;<span class="ref-vol">17</span>:750–6.</span> [<a href="/pubmed/24037103" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 24037103</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="hgc.REF.yamaguchi.2016.310">Yamaguchi T, Ishida H, Ueno H. Upper gastrointestinal tumours in Japanese familial adenomatous polyposis patients. <span><span class="ref-journal">Jpn J Clin Oncol. </span>2016;<span class="ref-vol">46</span>:310–5.</span> [<a href="/pmc/articles/PMC4886134/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4886134</span></a>] [<a href="/pubmed/26819281" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 26819281</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="hgc.REF.yoon.1999.177">Yoon KA, Ku JL, Yang HK, Kim WH, Park SY, Park JG. Germline mutations of E-cadherin gene in Korean familial gastric cancer patients. <span><span class="ref-journal">J Hum Genet. </span>1999;<span class="ref-vol">44</span>:177–80.</span> [<a href="/pubmed/10319582" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10319582</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="hgc.REF.zanghieri.1990.2047">Zanghieri G, Di Gregorio C, Sacchetti C, Fante R, Sassatelli R, Cannizzo G, Carriero A, Ponz de Leon M. Familial occurrence of gastric cancer in the 2-year experience of a population-based registry. <span><span class="ref-journal">Cancer. </span>1990;<span class="ref-vol">66</span>:2047–51.</span> [<a href="/pubmed/2224804" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 2224804</span></a>]</div></li></ul></div></div><div id="hgc.Chapter_Notes"><h2 id="_hgc_Chapter_Notes_">Chapter Notes</h2><div id="hgc.Revision_History"><h3>Revision History</h3><ul><li class="half_rhythm"><div>22 March 2018 (sw) Comprehensive update posted live</div></li><li class="half_rhythm"><div>31 July 2014 (me) Comprehensive update posted live</div></li><li class="half_rhythm"><div>21 June 2011 (me) Comprehensive update posted live</div></li><li class="half_rhythm"><div>31 August 2006 (pk) Revision: <a class="def" href="/books/n/gene/glossary/def-item/prenatal-diagnosis/">prenatal diagnosis</a> clinically available</div></li><li class="half_rhythm"><div>13 December 2004 (me) Comprehensive update posted live</div></li><li class="half_rhythm"><div>4 November 2002 (me) Review posted live</div></li><li class="half_rhythm"><div>5 April 2002 (pk) Original submission</div></li></ul></div></div><div id="bk_toc_contnr"></div></div></div>
            <div class="post-content"><div><div class="half_rhythm"><a href="/books/about/copyright/">Copyright</a> © 1993-2019, University of Washington, Seattle. GeneReviews is
a registered trademark of the University of Washington, Seattle. All rights
reserved.<p class="small">GeneReviews® chapters are owned by the University of Washington. Permission is
hereby granted to reproduce, distribute, and translate copies of content materials for
noncommercial research purposes only, provided that (i) credit for source (<a href="http://www.genereviews.org/" ref="pagearea=meta&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">http://www.genereviews.org/</a>) and copyright (© 1993-2019 University of
Washington) are included with each copy; (ii) a link to the original material is provided
whenever the material is published elsewhere on the Web; and (iii) reproducers,
distributors, and/or translators comply with the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>. No further modifications are allowed. For clarity, excerpts
of GeneReviews chapters for use in lab reports and clinic notes are a permitted
use.</p><p class="small">For more information, see the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>.</p><p class="small">For questions regarding permissions or whether a specified use is allowed,
contact: <a href="mailto:dev@null" data-email="ude.wu@tssamda" class="oemail">ude.wu@tssamda</a>.</p></div><div class="small"><span class="label">Bookshelf ID: NBK1139</span><span class="label">PMID: <a href="/pubmed/20301318" title="PubMed record of this page" ref="pagearea=meta&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">20301318</a></span></div><div style="margin-top:2em" class="bk_noprnt"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/hcp/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/hered-drta/" title="Next page in this title">Next &gt;</a></div></div></div></div>
            
        </div>

        <!-- Custom content below content -->
        <div class="col4">
            
        </div>
        
        
        <!-- Book content -->
        
        <!-- Custom contetnt below bottom nav -->
        <div class="col5">
            
        </div>
    </div>

    <div id="rightcolumn" class="four_col col last">
        <!-- Custom content above discovery portlets -->
        <div class="col6">
            <div id="ncbi_share_book"><a href="#" class="ncbi_share" data-ncbi_share_config="popup:false,shorten:true" ref="id=NBK1139&amp;db=books">Share</a></div>

        </div>
        <div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Views</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PDF_download" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/NBK1139/?report=reader">PubReader</a></li><li><a href="/books/NBK1139/?report=printable">Print View</a></li><li><a data-jig="ncbidialog" href="#_ncbi_dlg_citbx_NBK1139" data-jigconfig="width:400,modal:true">Cite this Page</a><div id="_ncbi_dlg_citbx_NBK1139" style="display:none" title="Cite this Page"><div class="bk_tt">Kaurah P, Huntsman DG. Hereditary Diffuse Gastric Cancer. 2002 Nov 4 [Updated 2018 Mar 22]. In: Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. <span class="bk_cite_avail"></span></div></div></li><li><a href="/books/NBK1139/pdf/Bookshelf_NBK1139.pdf">PDF version of this page</a> (293K)</li><li><a href="#" class="toggle-glossary-link" title="Enable/disable links to the glossary">Disable Glossary Links</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>In this GeneReview</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="page-toc" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="#hgc.Summary" ref="log$=inpage&amp;link_id=inpage">Summary</a></li><li><a href="#hgc.Diagnosis" ref="log$=inpage&amp;link_id=inpage">Diagnosis</a></li><li><a href="#hgc.Clinical_Characteristics" ref="log$=inpage&amp;link_id=inpage">Clinical Characteristics</a></li><li><a href="#hgc.Genetically_Related_Allelic_Disorder" ref="log$=inpage&amp;link_id=inpage">Genetically Related (Allelic) Disorders</a></li><li><a href="#hgc.Differential_Diagnosis" ref="log$=inpage&amp;link_id=inpage">Differential Diagnosis</a></li><li><a href="#hgc.Management" ref="log$=inpage&amp;link_id=inpage">Management</a></li><li><a href="#hgc.Genetic_Counseling" ref="log$=inpage&amp;link_id=inpage">Genetic Counseling</a></li><li><a href="#hgc.Resources" ref="log$=inpage&amp;link_id=inpage">Resources</a></li><li><a href="#hgc.Molecular_Genetics" ref="log$=inpage&amp;link_id=inpage">Molecular Genetics</a></li><li><a href="#hgc.References" ref="log$=inpage&amp;link_id=inpage">References</a></li><li><a href="#hgc.Chapter_Notes" ref="log$=inpage&amp;link_id=inpage">Chapter Notes</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>GeneReviews Links</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="source-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/n/gene/advanced/"><i>GeneReviews</i> Advanced Search</a></li><li><a href="/books/n/gene/glossary/"><i>GeneReviews</i> Glossary</a></li><li><a href="/books/n/gene/resource_mats/">Resource Materials</a> <span class="bk_hlight1">NEW FEATURE</span></li><li><a href="/books/n/gene/updates/">New in <i>GeneReviews</i></a></li><li><a href="/books/n/gene/authors/">Author List</a></li><li><a href="/books/n/gene/prospective_authors/">For Current/Prospective Authors</a></li><li><a href="/books/n/gene/GRpersonnel/"><i>GeneReviews</i> Personnel</a></li><li><a href="/books/n/gene/howto_linkin/">Download/Link to <i>GeneReviews</i></a></li><li><a href="/books/n/gene/contact_us/">Contact Us</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Tests in GTR by Gene</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="document-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=3845[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">KRAS</a></li><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=3557[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">IL1RN</a></li><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=999[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">CDH1</a></li><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=3553[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">IL1B</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Related information</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="discovery_db_links" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=omim&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_omim&amp;IdsFromResult=1472290" ref="log$=recordlinks">OMIM</a><div class="brieflinkpop offscreen_noflow">Related OMIM records</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pmc&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pmc_refs&amp;IdsFromResult=1472290" ref="log$=recordlinks">PMC</a><div class="brieflinkpop offscreen_noflow">PubMed Central citations</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pubmed&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pubmed_refs&amp;IdsFromResult=1472290" ref="log$=recordlinks">PubMed</a><div class="brieflinkpop offscreen_noflow">Links to PubMed</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=gene&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_gene&amp;IdsFromResult=1472290" ref="log$=recordlinks">Gene</a><div class="brieflinkpop offscreen_noflow">Locus Links</div></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Similar articles in PubMed</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PBooksDiscovery_RA" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/26072394" ref="ordinalpos=1&amp;linkpos=1&amp;log$=relatedarticles&amp;logdbfrom=pubmed">Accuracy of Hereditary Diffuse Gastric Cancer Testing Criteria and Outcomes in Patients With a Germline Mutation in CDH1.</a><span class="source">[Gastroenterology. 2015]</span><div class="brieflinkpop offscreen_noflow">Accuracy of Hereditary Diffuse Gastric Cancer Testing Criteria and Outcomes in Patients With a Germline Mutation in CDH1.<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">van der Post RS, Vogelaar IP, Manders P, van der Kolk LE, Cats A, van Hest LP, Sijmons R, Aalfs CM, Ausems MG, Gómez García EB, et al. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Gastroenterology. 2015 Oct; 149(4):897-906.e19. Epub 2015 Jun 11.</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/31853199" ref="ordinalpos=1&amp;linkpos=2&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> CDH1 (E-Cadherin) Mutation and Gastric Cancer: Genetics, Molecular Mechanisms and Guidelines for Management.</a><span class="source">[Cancer Manag Res. 2019]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> CDH1 (E-Cadherin) Mutation and Gastric Cancer: Genetics, Molecular Mechanisms and Guidelines for Management.<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Shenoy S. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Cancer Manag Res. 2019; 11:10477-10486. Epub 2019 Dec 13.</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/25979631" ref="ordinalpos=1&amp;linkpos=3&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Hereditary diffuse gastric cancer: updated clinical guidelines with an emphasis on germline CDH1 mutation carriers.</a><span class="source">[J Med Genet. 2015]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Hereditary diffuse gastric cancer: updated clinical guidelines with an emphasis on germline CDH1 mutation carriers.<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">van der Post RS, Vogelaar IP, Carneiro F, Guilford P, Huntsman D, Hoogerbrugge N, Caldas C, Schreiber KE, Hardwick RH, Ausems MG, et al. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">J Med Genet. 2015 Jun; 52(6):361-74. Epub 2015 May 15.</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/31600923" ref="ordinalpos=1&amp;linkpos=4&amp;log$=relatedarticles&amp;logdbfrom=pubmed">Identification of c.1531C&amp;gt;T Pathogenic Variant in the &lt;i&gt;CDH1&lt;/i&gt; Gene as a Novel Germline Mutation of Hereditary Diffuse Gastric Cancer.</a><span class="source">[Int J Mol Sci. 2019]</span><div class="brieflinkpop offscreen_noflow">Identification of c.1531C&amp;gt;T Pathogenic Variant in the &lt;i&gt;CDH1&lt;/i&gt; Gene as a Novel Germline Mutation of Hereditary Diffuse Gastric Cancer.<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Norero E, Alarcon MA, Hakkaart C, de Mayo T, Mellado C, Garrido M, Aguayo G, Lagos M, Torres J, Calvo A, et al. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Int J Mol Sci. 2019 Oct 9; 20(20). Epub 2019 Oct 9.</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301425" ref="ordinalpos=1&amp;linkpos=5&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> <i xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">BRCA1-</i> and <i xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">BRCA2</i>-Associated Hereditary Breast and Ovarian Cancer</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> <i xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">BRCA1-</i> and <i xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">BRCA2</i>-Associated Hereditary Breast and Ovarian Cancer<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Petrucelli N, Daly MB, Pal T. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li></ul><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed_reviews&amp;uid=20301318" ref="ordinalpos=1&amp;log$=relatedreviews_seeall&amp;logdbfrom=pubmed">See reviews...</a><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed&amp;uid=20301318" ref="ordinalpos=1&amp;log$=relatedarticles_seeall&amp;logdbfrom=pubmed">See all...</a></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Recent Activity</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="recent_activity" id="Shutter"></a></div><div class="portlet_content"><div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" id="HTDisplay" class=""><div class="action"><a href="javascript:historyDisplayState('ClearHT')">Clear</a><a href="javascript:historyDisplayState('HTOff')" class="HTOn">Turn Off</a><a href="javascript:historyDisplayState('HTOn')" class="HTOff">Turn On</a></div><ul id="activity"><li class="ra_rcd ralinkpopper two_line"><a class="htb ralinkpopperctrl" ref="log$=activity&amp;linkpos=1" href="/portal/utils/pageresolver.fcgi?recordid=5e040f5475f66d18aaba51f4">Hereditary Diffuse Gastric Cancer - GeneReviews®</a><div class="ralinkpop offscreen_noflow">Hereditary Diffuse Gastric Cancer - GeneReviews®<div class="brieflinkpopdesc"></div></div><div class="tertiary"></div></li></ul><p class="HTOn">Your browsing activity is empty.</p><p class="HTOff">Activity recording is turned off.</p><p id="turnOn" class="HTOff"><a href="javascript:historyDisplayState('HTOn')">Turn recording back on</a></p><a class="seemore" href="/sites/myncbi/recentactivity">See more...</a></div></div></div>
        
        <!-- Custom content below discovery portlets -->
        <div class="col7">
            
        </div>
    </div>
</div>

<!-- Custom content after all -->
<div class="col8">
    
</div>
<div class="col9">
    
</div>

<script type="text/javascript" src="/corehtml/pmc/js/jquery.scrollTo-1.4.2.js"></script>
<script type="text/javascript">
    (function($){
        $('.skiplink').each(function(i, item){
            var href = $($(item).attr('href'));
            href.attr('tabindex', '-1').addClass('skiptarget'); // ensure the target can receive focus
            $(item).on('click', function(event){
                event.preventDefault();
                $.scrollTo(href, 0, {
                    onAfter: function(){
                        href.focus();
                    }
                });
            });
        });
    })(jQuery);
</script>
                        </div>
                        <div class="bottom">
                            
                            <div id="NCBIFooter_dynamic">
    <a id="help-desk-link" class="help_desk" href="" target="_blank">Support Center</a>
    <a id="help-desk-link" class="help_desk" href="https://support.ncbi.nlm.nih.gov/ics/support/KBList.asp?Time=2019-12-25T20:39:32-05:00&amp;Snapshot=%2Fprojects%2Fbooks%2FPBooks@5.22&amp;Host=portal106&amp;ncbi_phid=CE8D35A4E03FF82100000000066001FE&amp;ncbi_session=CE8D35A4E040F531_1632SID&amp;from=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fbooks%2FNBK1139%2F&amp;Db=pmc&amp;folderID=134&amp;Ncbi_App=bookshelf&amp;Page=literature&amp;style=classic&amp;deptID=28049" target="_blank">Support Center</a>
    
</div>

                            <div class="footer" id="footer">
    
    <div class="subfooter"> </div><script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/preloaderWidget.js"> </script>
    <div id="external-disclaimer" class="offscreen_noflow">
        External link. Please review our <a href="https://www.nlm.nih.gov/privacy.html">privacy policy</a>.
    </div>    
    <div id="ncbifooter" class="contact_info">      
        <div id="footer-contents-right">
            <div id="nlm_thumb_logo">
                <a href="https://www.nlm.nih.gov" title="NLM">NLM</a>
            </div>
            <div id="nih_thumb_logo">
                <a href="https://www.nih.gov" title="NIH">NIH</a>
            </div>
            <div id="hhs_thumb_logo">
                <a href="https://www.hhs.gov" title="DHHS">DHHS</a>
            </div>
            <div id="usagov_thumb_logo">
                <a href="https://www.usa.gov" title="USA.gov">USA.gov</a>
            </div>         
        </div>
        
        <div id="footer-contents-left">
            <p class="address vcard">
                <span class="url">
                    <a class="fn url newdomain" href="https://www.ncbi.nlm.nih.gov">National Center for
                        Biotechnology Information</a>,
                </span> <span class="org url newdomain"><a href="https://www.nlm.nih.gov/">U.S. National Library of Medicine</a></span>
                <span class="adr">
                    <span class="street-address">8600 Rockville Pike</span>, <span class="locality">Bethesda</span>
                    <span class="region">MD</span>, <span class="postal-code">20894</span>
                    <span class="country-name">USA</span>
                </span>
            </p>
            
            <a href="/home/about/policies.shtml">Policies and Guidelines</a> | <a href="/home/about/contact.shtml">Contact</a>
        </div>
    </div>
    <script type="text/javascript" src="/portal/portal3rc.fcgi/rlib/js/InstrumentOmnitureBaseJS/InstrumentNCBIConfigJS/InstrumentNCBIBaseJS/InstrumentPageStarterJS.js?v=1"> </script>    
    <script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/hfjs2.js"> </script>
</div>
                        </div>
                    </div>
                    <!--/.page-->
                </div>
                <!--/.wrap-->
            </div><!-- /.twelve_col -->
        </div>
        <!-- /.grid -->

        <span class="PAFAppResources"></span>
        
        <!-- BESelector tab -->
        
        
        
        <noscript><img alt="statistics" src="/stat?jsdisabled=true&amp;ncbi_db=books&amp;ncbi_pdid=book-part&amp;ncbi_acc=NBK1139&amp;ncbi_domain=gene&amp;ncbi_report=record&amp;ncbi_type=fulltext&amp;ncbi_objectid=&amp;ncbi_pcid=/NBK1139/&amp;ncbi_pagename=Hereditary Diffuse Gastric Cancer - GeneReviews® - NCBI Bookshelf&amp;ncbi_bookparttype=chapter&amp;ncbi_app=bookshelf" /></noscript>
        
        
        <!-- usually for JS scripts at page bottom -->
        <!--<component id="PageFixtures" label="styles"></component>-->
    

<!-- CE8D35A4E040F531_1632SID /projects/books/PBooks@5.22 portal106 v4.1.r585844 Mon, May 06 2019 02:53:16 -->

<script type="text/javascript" src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/js/3879255/4121861/3501987/4008961/3893018/3821238/4062932/4123007/4087685/4076480/3921943/3400083/3426610.js" snapshot="books"></script></body>
</html>